Podcasts about A1C

In today's episode Eoin chats with Jason Ziobrowski (Chef Jay Z).Today's guest brings flavor, passion, and purpose to everything he does. Jason Ziobrowski — or as many know him, Chef Jay-Z — has spent nearly two decades as a corporate R&D chef, creating recipes and nutrition programs for hospitals, patients, and communities. His mission? To influence people positively through food and to help change the American palate, one dish at a time.But behind the chef's coat is a deeply personal journey. After years of being told he was simply ‘pre-diabetic,' Jason was finally diagnosed in 2020 with type 1.5 diabetes. At the time, his fasting sugars were nearly 22.2mmol/L (400mg/dL), and his A1C hit 14.Instead of giving up, Jason took charge. He overhauled his lifestyle cold turkey, dropping his fasting sugars down into a healthy range and transforming not just his health, but his outlook on life.Today, Chef Jay-Z is thriving with type 1, using technology like the Medtronic pump, leaning on his family, and continuing to inspire others through food, education, and his own story of resilience. From hospital kitchens to his own blood sugar battles, Jason has learned that lifestyle change isn't just necessary — it can be one of the best things to ever happen to you.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

***JOIN THE NEXT MASTER YOUR FASTING CHALLENGE THAT STARTS October 1st, 2025!*** We'll GUIDE you on how to FAST to LOSE FAT for good, and use ‘fast cycling' to achieve uncommon results! ⁠REGISTER HERE!⁠ Click the link for DATES, DETAILS, and FAQs! This episode examines a critical 2025 systematic review and meta-analysis of 12 randomized controlled trials involving 966 type 2 diabetic participants, revealing a sobering truth about intermittent fasting: while it produces remarkable short-term benefits, these gains completely disappear after discontinuation. Dr. Scott and Tommy analyze how various fasting protocols (time-restricted eating, fast-mimicking diets, periodic fasting) significantly reduced A1C levels, fasting blood glucose, and body weight in under three months - but all parameters returned to pre-intervention levels within three months of stopping. This research powerfully illustrates why fasting must be approached as a permanent lifestyle change rather than a temporary diet solution. The hosts address the staggering diabetes epidemic: 38 million diagnosed Americans, 9 million undiagnosed, and 98 million with prediabetes - totaling 145 million Americans on the diabetes spectrum. Learn why the "rebound effect" occurs when fasting habits aren't sustained, and discover practical strategies for long-term adherence through personal anecdotes about adapting fasting to real-life situations like family dinners and social pressures. The episode introduces the concept of "momentary maintenance" - deliberate pauses in fat loss to build confidence in weight control rather than viewing plateaus as failures. This research validates that consistency trumps perfection, emphasizing that intermittent fasting works brilliantly when maintained but requires the same ongoing commitment as any other health practice to preserve its metabolic benefits. ⁠⁠⁠Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting!⁠⁠⁠⁠⁠⁠⁠⁠ Resources and Downloads: ⁠⁠⁠⁠⁠⁠⁠⁠SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! ⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS!⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠SLEEP GUIDE DIRECT DOWNLOAD⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE!⁠⁠⁠⁠⁠⁠⁠⁠ Partner Links: Get your⁠⁠⁠⁠⁠⁠⁠⁠ FREE BOX OF LMNT⁠⁠⁠⁠⁠⁠⁠⁠ hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase⁠⁠⁠⁠⁠⁠⁠⁠ here!⁠⁠⁠⁠⁠⁠⁠⁠ Get ⁠⁠⁠⁠⁠⁠⁠⁠25% off a Keto-Mojo⁠⁠⁠⁠⁠⁠⁠⁠ blood glucose and ketone monitor (discount shown at checkout)! ⁠⁠⁠⁠⁠⁠⁠⁠Click here!⁠⁠⁠⁠⁠⁠⁠⁠ Our Community: Let's continue the conversation. Click the link below to JOIN the ⁠⁠⁠⁠⁠⁠⁠⁠Fasting For Life Community⁠⁠⁠⁠⁠⁠⁠⁠, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them! Article Links:⁠ https://www.sciencedirect.com/science/article/pii/S0271531725000600?via%3Dihub

Beverly Spring shares her powerful journey from chronic migraines and type 2 diabetes to improved health through faith-centered wellness. She discovers how integrating spiritual practices with nutrition and movement transformed her life despite multiple health challenges and family caregiving responsibilities.• Beverly suffered from chronic migraines since childhood but went "chronic" in the early 2000s• She discovered many of her migraine triggers were foods she naturally disliked—her body's innate intelligence protecting her• Medication for high cholesterol likely contributed to her type 2 diabetes diagnosis• Through Fast to Faith, Beverly reduced her A1C from 6.4 to 6.0, moving from diabetes to pre-diabetes range• She developed flashcards with scripture to replace negative self-talk with biblical truth• Simple stretching routines have significantly improved her neck and shoulder pain• Beverly completed the Fast to Faith coaching program despite undergoing shoulder surgery and caring for her husband after his double bypass• God's perfect timing allowed her own healing to progress enough to help her husband through his recoveryNever give up on your health journey—start where you are, even when circumstances aren't perfect. God cannot steer a parked car, so get into "messy action" and let Him direct your path.Women's Wellness Retreat at The Meadows on Rock Creek in beautiful Montana! Four days of faith-based wellness, hormone balance, clean living tips, and pure restoration—plus hiking, yoga, horseback riding, and gourmet meals in luxury cabins. Spots are limited, so grab your ticket today and let's do this together! https://themeadowsonrockcreek.com/special-events/womens-wellness-retreat/Thank you for listening to the Fast to Faith Podcast. Midlife Isn't a Crisis — It's Your Wake-Up Call Feeling stuck, restless, or like something's missing — even though you've checked all the boxes? It's not “just hormones,” and it's definitely not all in your head. The Midlife Reset Summit is here to help you uncover what's really holding you back — and give you the tools to break free. Join me and a powerhouse lineup of experts as we pull back the curtain on the hidden patterns, beliefs, and pressures that keep midlife women playing small. It's time to reclaim your energy, your clarity, and your confidence — and step fully into the next chapter with purpose.

We have a wonderful program in store for you this Saturday as The Word on Medicine brings you into the world of diabetes and specifically, Type 2 Diabetes - such an important topic in our society today. Dr. Michael (Mickey) Voss and Lisa Sherlock (RD, CDCES) will be joined by one of their patients in this fact-filled program. For those of you who are confused by A1C, insulin pumps, continuous glucose monitoring, and the difference between type 1 and type 2 diabetes, spend some time with The Word on Medicine, we will help you!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

Dr. Vera Tarman sits down with Dr. Bart Kay—former professor of health sciences turned “nutrition science watchdog”—to unpack a big, practical question for people in recovery from ultra-processed food use: If sugar needs to go, what about other carbs? And where does dietary fat fit in? We explore Dr. Kay's perspective on the Randle (Randall) cycle, insulin resistance, mixed macro diets, seed oils, ketogenic/carnivore patterns, and real-world considerations for folks with sugar/UPF addiction who struggle to “moderate.” We also discuss staged change (don't flip your diet overnight), what “abstainer vs. moderator” can mean in food recovery, and how to keep any nutrition experiment aligned with your health team and your recovery plan. What we cover The “Randle cycle,” plain-English: why mixing higher carbs and higher fats may worsen metabolic friction, and why choosing one dominant fuel is central to Dr. Kay's model. Insulin resistance re-framed: why Dr. Kay views it as a protective cellular response (his position) and how that informs low-carb/carnivore advocacy. Carbs in recovery: “quit sugar” vs. “how low is low?”—Dr. Kay's thresholds (e.g., ≤50 g/day unlikely to cause problems in his view) and why many with UPF addiction do better with abstinence than moderation. Fats & satiety: why dietary fat often increases fullness cues; practical guardrails; “can you eat too much fat or protein?” Seed oils: Dr. Kay's strong critique of industrial seed oils and his inflammation concerns. Cholesterol worries on low-carb/carnivore: why lipid numbers may rise and how Dr. Kay interprets A1C and lipid changes (controversial; see note below). GLP-1s, metformin & meds: Dr. Kay's take on drug mechanisms vs. root-cause nutrition changes. Change management: why he recommends a 4–6 week ramp instead of an overnight switch to very low-carb/carnivore; supporting thyroid, energy, and the microbiome while you transition. Recovery lens: abstainer vs. moderator, harm-reduction steps when “only food will regulate,” and building a plan that supports mental health and addiction recovery. Key takeaways Abstinence can be a kindness. If you're a “can't moderate sugar” person, treating sugar/UPFs as an abstinence-worthy trigger can protect your recovery. Don't crash-diet your microbiome. If you're experimenting with lower-carb or carnivore, step down over 4–6 weeks with plenty of electrolytes, hydration, and support. Pick a lane with macros. In Dr. Kay's model, mixing higher carbs with higher fats is the most metabolically problematic; choosing one dominant fuel source may reduce friction. Numbers are data, not destiny. Lipids and A1C can shift on low-carb—interpret changes with a clinician who understands your whole picture (medical history, meds, symptoms, goals). Harm-reduction still counts. If full abstinence isn't feasible today: remove red-light foods first, shrink access, use “pause + plan” tools, and reach out before the binge. About our guest Dr. Bart Kay is a former professor of human physiology, nutrition, and vascular pathophysiology with teaching/research stints in New Zealand, Australia, the UK, and the US. He's consulted for elite sport and defense organizations and now educates the public on YouTube as a self-described nutrition myth-buster. One of his core topics is the Randle cycle and its implications for diet composition. Dr. Kay's YouTube: https://www.youtube.com/@Professor-Bart-Kay-Nutrition   The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

Episode 25:37 Here's 4 Ways To Lower Your A1C Level Naturally  More than 100 million Americans have elevated blood sugar levels… and don't even know it! Another 50 million have elevated levels and DO know it. That's not good! It's not good because elevated blood sugar levels lead to deadly sicknesses and diseases. Disease such as Obesity, Type 2 Diabetes, Heart Disease, Cancer, Alzheimer's and Dementia. So, how do you know if blood sugar levels are elevated? It's easy! Simply have your doctor order a blood test known as an “A1C Test.” If your A1C score is above 5.4 it's considered to be elevated (high).  It also places you at high risk for developing any of the diseases mentioned above. Fortunately, elevated levels of blood sugar… high A1C levels… can be reduced naturally, without drugs. On this episode I discuss four specific tactics for doing just that. Four lifestyle habits that you can begin to implement immediately that will help reduce your blood sugar levels and decrease your risk of developing a chronic disease.  Be sure to give this episode a good listen and, as always, share it with a friend. Thanks! ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the “Symptom Survey” and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

               * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Christian holds a B.S. in Nutrition & Dietetics (Clemson), a Master's in Kinesiology (Cal State Fullerton, biomolecular exercise phys lab), is a CF-L1 since 2017, and was mentored by Dr. Andy Galpin. He's the founder of Sherpa Frontier, a physiology-first coaching company for elite athletes and high performers.What we cover (fast, actionable, no fluff):-Physiology-First: Why principles beat methods and how to pull the right levers (nutrition, sleep, training, blood sugar, recovery).-Blood Work That Actually Matters: Hidden markers (MCV, homocysteine, SHBG, A1C, CRP) that explain your plateau and what to do next.-Performance Fueling (No Fads): Carbs for output, macros that match training, and timing that kills crashes.-Recovery > Redlines: Readiness, HRV, and the “adaptation currency” mindset.-Coaching with a Blind Spot: How a legally blind coach developed elite-level cueing and communication.If you're done guessing and want measurable progress… this episode your blueprint.

***JOIN THE NEXT MASTER YOUR FASTING CHALLENGE THAT STARTS October 1st, 2025!*** We'll GUIDE you on how to FAST to LOSE FAT for good, and use ‘fast cycling' to achieve uncommon results! REGISTER HERE! Click the link for DATES, DETAILS, and FAQs! This episode examines a comprehensive narrative review analyzing fasting's profound effects on metabolic hormones and functions across 13 different studies and fasting protocols. Dr. Scott and Tommy reveal a game-changing mental approach: shift from counting down your fasting timer to counting up the powerful benefits accumulating in your body during each fast. The research demonstrates remarkable results from consistent intermittent fasting practices - 24-hour fasts performed three times weekly in women produced increased antioxidant activity, weight reduction, improved morning glucose levels, better A1C readings, and significant improvements in blood pressure, cholesterol, and triglycerides. Learn how 16:8 time-restricted eating for 12 weeks dramatically enhanced multiple metabolic markers in patients with metabolic syndrome, while understanding the crucial differences between fasting effects in lean individuals versus those with excess weight. The hosts clarify testosterone concerns, explaining why lean men may see temporary decreases with extended fasting protocols (typically due to inadvertent under-eating) while overweight men experience increases through improved testicular function and reduced estrogen conversion. Discover practical strategies for building sustainable fasting habits through progressive skill development rather than perfectionist approaches, including proper electrolyte management, leveraging gut microbiome improvements, and strategic meal planning for optimal fast-breaking. This episode reframes fasting as a learnable skill requiring practice and adaptation, providing specific guidance for developing your personal fasting toolkit based on your health status, body composition, and long-term metabolic optimization goals. ⁠⁠Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting!⁠⁠⁠⁠⁠⁠⁠ Resources and Downloads: ⁠⁠⁠⁠⁠⁠⁠SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! ⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS!⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠SLEEP GUIDE DIRECT DOWNLOAD⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE!⁠⁠⁠⁠⁠⁠⁠ Partner Links: Get your⁠⁠⁠⁠⁠⁠⁠ FREE BOX OF LMNT⁠⁠⁠⁠⁠⁠⁠ hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase⁠⁠⁠⁠⁠⁠⁠ here!⁠⁠⁠⁠⁠⁠⁠ Get ⁠⁠⁠⁠⁠⁠⁠25% off a Keto-Mojo⁠⁠⁠⁠⁠⁠⁠ blood glucose and ketone monitor (discount shown at checkout)! ⁠⁠⁠⁠⁠⁠⁠Click here!⁠⁠⁠⁠⁠⁠⁠ Our Community: Let's continue the conversation. Click the link below to JOIN the ⁠⁠⁠⁠⁠⁠⁠Fasting For Life Community⁠⁠⁠⁠⁠⁠⁠, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them! Article Links: https://pmc.ncbi.nlm.nih.gov/articles/PMC11560338/pdf/2188-2126-70-5-0348.pdf

Gestational diabetes (GDM) is one of the most common health issues during pregnancy, and diagnosing it is more complicated than you might think. In this episode, Dr. Dekker is joined by EBB Research Team member Dr. Morgan Richardson Cayama to cover the newly updated evidence on how GDM is diagnosed. They walk through the physiology behind GDM, current testing methods, and why there's still international disagreement about how to screen. Together, they examine the results of large randomized trials comparing the one-step and two-step screening methods, the research on early screening with hemoglobin A1C, and the evidence on alternatives to the Glucola drink, including candy and home blood sugar monitoring. They also review the risks of skipping screening entirely, and how weight bias and other systemic factors can impact diagnosis and care.   (02:28) What is Gestational Diabetes and Why Is It So Common? (06:30) Risk Factors, Size Bias, and the Role of Race and Ethnicity (10:40) Why We Screen and the Origins of the Controversy (13:17) Comparing the One-Step and Two-Step Methods (19:55) What New Research Says About Health Outcomes (23:45) Should We Screen for GDM Earlier in Pregnancy? (28:11) Can Hemoglobin A1C Replace the Glucola Drink? (32:44) Alternatives: Candy, Food, and Home Monitoring (40:04) What International Guidelines Recommend (43:07) Declining GDM Testing: What the Evidence Shows (47:47) Is Sperm Linked to Gestational Diabetes Risk? (51:29) Takeaways and the Future of GDM Diagnosis   Resources Download the free two-page handout in English or Spanish [NEED LINK] Explore Real Food for Gestational Diabetes by Lily Nichols: realfoodforgd.com For a full list of resources, visit ebbirth.com/inducinggdm For more information about Evidence Based Birth® and a crash course on evidence based care, visit www.ebbirth.com. Follow us on Instagram and YouTube! Ready to learn more? Grab an EBB Podcast Listening Guide or read Dr. Dekker's book, "Babies Are Not Pizzas: They're Born, Not Delivered!" If you want to get involved at EBB, join our Professional membership (scholarship options available) and get on the wait list for our EBB Instructor program. Find an EBB Instructor here, and click here to learn more about the EBB Childbirth Class.

What if the first signs of metabolic breakdown aren't in the pancreas or the blood sugar but hidden deep in the liver?In this episode of ReInvent Healthcare, Dr. Ritamarie takes you inside the metabolic feedback loop few practitioners are trained to detect. Long before glucose rises or A1C shifts, subtle signals in the liver may already be pointing to a much bigger problem. They're easy to miss, unless you know where to look. Discover the early biochemical whispers of insulin resistance, the hidden drivers of liver fat accumulation, and the lab markers most clinicians overlook. If your clients “look normal” on paper but still struggle, this is the episode you can't afford to skip.What's Inside This Episode?The silent organ shift that can signal metabolic trouble before blood sugar ever changesA hidden fat-making process your body might be running without your consentHow a sweet addiction quietly derails liver function and energy productionThe overlooked lab markers that whisper metabolic distress long before diagnosisA little-known score that could change how you assess “normal” labsSimple but strategic actions that tip the scales from fatty liver to functional healthHow small shifts in timing and nutrients may unlock powerful liver regenerationWhy stable glucose isn't the full story, and the signal you might be missingResources and Links:Download our FREE Metabolic Health Guide here. Here is a FIB-4 Calculator Tool FIB-4 = (Age × AST) / (Platelets × √ALT)NAFLD fibrosis score (NFS) = -1.675 + (0.037 × age) + (0.094 × BMI) + (1.13 × hyperglycemia) + (0.99 × AST/ALT ratio) - (0.013 × platelet count) - (0.66 × albumin)Join the Next-Level Health Practitioner Facebook group here for free resources and community supportVisit INEMethod.com for advanced health practitioner training and tools to elevate your clinical skills and grow your practice by getting life-changing results. Check out other podcast episodes here

Can you really rebuild your insulin sensitivity and one day enjoy the occasional treat again? Why does your blood sugar sometimes skyrocket out of the blue, even when you've done nothing differently? And what's the real story with berberine, sugar-free drinks, and breakfast foods that claim to be healthy? In this Diabetes Q&A episode we answer these practical, often confusing questions straight from listeners just like you. You'll hear about managing stubborn high A1c levels in diabetes even after years on insulin, how infections can secretly wreak havoc on your blood sugar, and why a typical “healthy” breakfast might actually be sabotaging your efforts. Plus, we clear up what research really says about berberine and liver health, whether diet sodas are truly safe, and how protein can change the game for your insulin response.If you have a question or topic suggestion, be sure to send it in for a future Q&A!For show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

In this episode, I'm joined by Carly Piehl, a 35-year-old mom and wife who was diagnosed with type 1 diabetes in late 2024 while in DKA, with no family history and no warning signs. Carley opens up about what those first overwhelming months were really like, from being sent home from the ER with a 13 A1C to navigating both the emotional and blood sugar rollercoaster. Despite early progress, she still felt stuck and frustrated until she found our signature group coaching program and discovered a new way to live with T1D. We talk about what it looks like to build confidence with food, technology, and mindset, especially while managing the daily demands of motherhood and marriage + the secret to her FIVE POINT A1C DROP. This episode is dedicated to anyone out there who has ever thought: Will I ever make peace with T1D? Quick Takeaways: The #1 thing that helped Carley make this transformation of lowering A1C from 13 to below 8.0 How to build confidence with food, technology, and mindset–especially while managing the daily demands of motherhood and marriage Advice AND treatment everyone should receive at diagnosis“That's when I realized, I was going to need to find other people who had diabetes to learn…”

In this episode, Dr Jedha speaks with Susan, a vibrant 71-year-old who shares her honest journey of managing prediabetes, lowering her A1c, and improving her cholesterol, by taking the Prediabetes Reset Program. Despite a lifetime of being told she could eat anything she wanted, Susan faced a wake-up call when her blood sugar numbers crept into the prediabetes range. With a little encouragement and practical tools, she chose to embrace change and discovered how small, mindful shifts could make a big difference.Susan opens up about navigating temptations, letting go of old fears around healthy fats, and finding satisfaction without feeling deprived. She also highlights the power of support, consistent guidance, and learning to be patient with yourself along the way.Susan's story is a reminder that it's never too late to make meaningful changes, enjoy delicious food, and live life more fully, even well into your 70s!Need help to reverse your prediabetes? Join Dr Jedha's Prediabetes Reset Program: https://diabetesmealplans.com/prediabetes-reset-program/For show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

In this episode, we shine a spotlight on insulin—an often overlooked but crucial hormone that plays a central role in metabolism and overall health. While blood sugar gets a lot of attention, insulin is the key regulator behind it, influencing energy storage, fat metabolism, and cellular function. We explore how insulin resistance develops, the early signs to watch for, and why it's so important to address this root issue to prevent chronic disease. We also discuss how ketogenic and low-carb diets can help regulate insulin levels, improve metabolic flexibility, and support weight management. This episode provides clear, functional insights into insulin's role and practical strategies for balancing it through nutrition and lifestyle, making it a must-listen for anyone interested in metabolic health and disease prevention. Also in this episode:  Keto Reset Program - Enrollment opens 8/28! Episode 76 Getting to the root of insulin resistance What is insulin and why does it matter? What is insulin resistance? What causes insulin resistance? How does it develop on a cellular level?  What are signs and symptoms of insulin resistance? How do we test for insulin resistance? Fasting insulin

Episode 25:34 Knowing Your INSULIN Level Is As Important As Knowing Your Blood Sugar Level. Here's Why…   Most doctors, when ordering blood work for a patient, will include an A1C test. This is wise because an A1C test will reveal what a person's blood sugar has been, on average, over the previous three months. Ideally, your A1C score should be below 5.7 (my preference is for it to be 5.4 or less). A score between 5.7 and 6.4 reflects Prediabetes, while a score of 6.5 or above is considered to be Diabetic. But there's a problem with this: A person's A1C score is NOT the only indicator of blood sugar issues. Or, stated another way, a person can have a normal A1C score and still have SEVERE blood sugar issues. How? By having elevated Insulin levels! On this episode I share the story of a patient of mine whose blood sugar levels were okay… but his Insulin levels were through the roof! In fact, his Insulin levels were so high that he was, in my opinion, a walking time bomb. However, because he had his Insulin levels tested… something MOST doctors don't do… we were able to identify this problem and address it accordingly. Be sure to give this episode a good listen as understanding the role of Insulin, and the importance of having it tested, is critically important for anyone who cares about their health.  And, as always, please share it with a friend. Thanks!  ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the “Symptom Survey” and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)  

           * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.What does it look like to fully own your story with Type 1 diabetes and stop letting the condition define you? In this episode, I sit down with Rob Howe—former professional basketball player, creator of Diabetics Doing Things, and passionate advocate for the T1D community. Rob shares how sports shaped his relationship with diabetes, why storytelling matters in this space, and what it takes to break free from shame, comparison, and limiting beliefs. This is a powerful conversation about redefining what's possible while living with T1D.Key TakeawaysYour story matters — Why sharing your journey helps both you and the T1D community.Shame doesn't belong here — How to stop letting diabetes define your self-worth.Beyond the numbers — A1C isn't everything—focus on real life, not perfection.Lessons from sports — How discipline, resilience, and community carry over from the court into daily diabetes life.Building community — Why connection and storytelling create hope and belonging.Resources & Links Mentioned in This Episode

Join Board Certified Functional Health Practitioner Dee Davidson, FDN-P as she sits down with her past client Joanne, who shares her surprising journey after receiving lab results post-annual physical. From the outside, Joanne looked like the picture of health—fit, active, eating mostly clean, and full of life. But her A1C told a different story: it was elevated, leaving her mind boggled and confused.In this episode, Joanne opens up about:What she learned about blood sugar regulation (hint: it's not just about sweets!)How functional lab testing helped uncover underlying imbalancesThe shifts she made with Dee's guidance to bring her A1C back into rangeWhy insulin is a hormone—and how dysregulation can show up in surprising waysYou do not need to be overweight to have insulin resistance or type 2 diabetes. This episode is a powerful reminder that symptoms don't always tell the full story, and labs don't lie.Ready to see what your labs are really saying?Click here to book a session with DeeFollow Dee on Instagram for tips, insights, and inspiration:@confidently_love_yourselfMedical Disclaimer: This podcast is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any medical condition. Always consult your physician before making any changes to your health routine.

Let's be real - there's a LOT of bad diabetes advice floating around on TikTok, Instagram, and even from well-meaning doctors. In this episode, I'm calling out some of the most common myths, from “A1C under 7 means you're fine” to “low carb fixes everything” to “fruit is the enemy.” We'll dig into why these ideas stick, what the real story is, and how to think smarter about your numbers, food choices, and insulin without falling for the internet nonsense! Come see what the hype is all about! Your spot in the Blood Sugar Club is ready ➡️https://www.yourdiabetesinsider.com/blood-sugar-club Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff Watch my food breakdowns here → https://www.youtube.com/@yourdiabetesinsider   LET'S TALK! Instagram: @manoftzeel Tiktok: @manoftzeel

In this episode, Chris Reade shares his personal journey of overcoming diabetes through lifestyle changes and the importance of soluble fiber in managing blood sugar levels. He discusses the rapid onset of his diabetes diagnosis, the shift in his medical guidance, and practical strategies for maintaining a healthy lifestyle. Chris emphasizes the significance of self-forgiveness, the role of exercise, and the importance of monitoring progress in the journey to beating diabetes.TakeawaysChris Reade experienced a rapid onset of diabetes that shocked him into action.He refused to accept a lifelong dependency on medication for diabetes.Chris discovered the importance of soluble fiber in controlling blood sugar levels.His approach to managing diabetes is not a diet but a sustainable lifestyle change.Self-forgiveness is crucial in the journey of managing diabetes.Practical strategies include eating soluble fiber before meals to prevent blood sugar spikes.Regular exercise, even walking, can significantly lower blood sugar levels.Monitoring A1C levels helps reinforce positive health behaviors.Chris emphasizes the need for easy-to-follow food choices to maintain a healthy lifestyle.His book, 'Beating Diabetes', provides insights and strategies for others facing similar challenges.About Chris Reade Chris Reade is a technology executive, author, and lifelong entrepreneur who started his first company at the age of 19. Known for his solution-centered mindset, Chris approaches every challenge with practical, real-world solutions, optimism, and good cheer. His journey to overcome type 2 diabetes gained him recognition as he faced a significant increase in his A1C levels—an indicator of blood glucose levels. Determined to take control of his health, Chris embarked on a transformative path to manage and ultimately reverse his diabetes through lifestyle changes rather than relying solely on medication. He shares his experiences and insights in his book titled "Beating Diabetes," where he outlines effective strategies for managing blood sugar levels, emphasising the importance of soluble fibre and sustainable dietary choices. Chris's story serves as an inspiration for many dealing with diabetes, showcasing the potential to reclaim health through informed lifestyle adjustments and a positive approach to problem-solving. About Beating Diabetes

Evo & Gregg dive into guilty pleasure nostalgia—90s & 2000s reality shows that defined an era. From Flavor of Love to Room Raiders, we unpack what your faves say about you. Plus: an A1C health update, Pokemail, MCU rewatch (Incredible Hulk → Avengers), a farewell to AOL Dial-Up, Wednesday binge talk, comic hauls, antique finds, fast food throwbacks (Carl's Jr. & Jack in the Box), summer breakfasts, and unforgettable childhood summers.✨ Call to Action:Tell us your fave summer soundtrack, your go-to ice cream truck order, and your back-to-school prep traditions!Check out these other awesome podcastsScreaming Meemies PodcastPokebeach.com Pokemon TCG PodcastFlesh and Code⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠MetaPod: A Pokemon TCG Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rivals Assemble: A Marvel Rivals Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check out these delicious treats from ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cakes and More By Sabrina⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Fulltime home baker. Let her be your cake lady.Listen to other amazing podcasters or just hang out with our amazing network by following our socials. For more on that check us out at.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linktree.com/m3pnetwork⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Become a member of the My 3rd Place Network Community and watch me live stream the podcast nightly on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠tiktok/evolutionofageek⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠email us m3pnetwork@gmail.com#M3PPodcast #NostalgiaPodcast #RealityTV #90sNostalgia #2000sVibes #SummerMemories #MCURewatch #ComicHaul #RetroInternet #BackToSchool #Pokemail #FastFoodNostalgia

This is a hybrid heart disease risk factor post of a podcast with Prof Bruce Lanphear on lead and a piece I was asked to write for the Washington Post on risk factors for heart disease.First, the podcast. You may have thought the problem with lead exposure was circumscribed to children, but it's a much bigger issue than that. I'll concentrate on the exposure risk to adults in this interview, including the lead-estrogen hypothesis. Bruce has been working on the subject of lead exposure for more than 30 years. Let me emphasize that the problem is not going away, as highlighted in a recent New England Journal of Medicine piece on lead contamination in Milwaukee schools, “The Latest Episode in an Ongoing Toxic Pandemic.”Transcript with links to the audio and citationsEric Topol (00:05):Well, hello. This is Eric Topol with Ground Truths, and I'm very delighted to welcome Professor Bruce Lanphear from Simon Fraser University in British Columbia for a very interesting topic, and that's about lead exposure. We tend to think about lead poisoning with the Flint, Michigan, but there's a lot more to this story. So welcome, Bruce.Bruce Lanphear (00:32):Thank you, Eric. It's great to be here.Eric Topol (00:33):Yeah. So you had a New England Journal of Medicine (NEJM) Review in October last year, which was probably a wake up to me, and I'm sure to many others. We'll link to that, where you reviewed the whole topic, the title is called Lead Poisoning. But of course it's not just about a big dose, but rather chronic exposure. So maybe you could give us a bit of an overview of that review that you wrote for NEJM.Bruce Lanphear (01:05):Yeah, so we really focused on the things where we feel like there's a definitive link. Things like lead and diminished IQ in children, lead and coronary heart disease, lead and chronic renal disease. As you mentioned, we've typically thought of lead as sort of the overt lead poisoning where somebody becomes acutely ill. But over the past century what we've learned is that lead is one of those toxic chemicals where it's the chronic wear and tear on our bodies that catches up and it's at the root of many of these chronic diseases that are causing problems today.Eric Topol (01:43):Yeah, it's pretty striking. The one that grabbed me and kind of almost fell out of my chair was that in 2019 when I guess the most recent data there is 5.5 million cardiovascular deaths ascribed to relatively low levels, or I guess there is no safe level of lead exposure, that's really striking. That's a lot of people dying from something that cardiology and medical community is not really aware of. And there's a figure 3 [BELOW] that we will also show in the transcript, where you show the level where you start to see a takeoff. It starts very low and by 50 μg/liter, you're seeing a twofold risk and there's no threshold, it keeps going up. How many of us do you think are exposed to that type of level as adults, Bruce?Bruce Lanphear (02:39):Well, as adults, if we go back in time, all of us. If you go back to the 1970s when lead was still in gasoline, the median blood lead level of Americans was about 13 to 15 µg/dL. So we've all been exposed historically to those levels, and part of the reason we've begun to see a striking decline in coronary heart disease, which peaked in 1968. And by 1978, there was a 20% decline, 190,000 more people were alive than expected. So even in that first decade, there was this striking decline in coronary heart disease. And so, in addition to the prospective studies that have found this link between an increase in lead exposure and death from cardiovascular disease and more specifically coronary heart disease. We can look back in time and see how the decline in leaded gasoline led to a decline in heart disease and hypertension.Eric Topol (03:41):Yeah, but it looks like it's still a problem. And you have a phenomenal graph that's encouraging, where you see this 95% reduction in the lead exposure from the 1970s. And as you said, the factors that can be ascribed to like getting rid of lead from gasoline and others. But what is troubling is that we still have a lot of people that this could be a problem. Now, one of the things that was fascinating is that you get into that herbal supplements could be a risk factor. That we don't do screening, of course, should we do screening? And there's certain people that particularly that you consider at high risk that should get screened. So I wasn't aware, I mean the one type of supplements that you zoomed in on, how do you say it? Ayurvedic?Supplements With LeadBruce Lanphear (04:39):Oh yeah. So this is Ayurvedic medicine and in fact, I just was on a Zoom call three weeks ago with a husband and wife who live in India. The young woman had taken Ayurvedic medicine and because of that, her blood lead levels increased to 70 µg/dL, and several months later she was pregnant, and she was trying to figure out what to do with this. Ayurvedic medicine is not well regulated. And so, that's one of the most important sources when we think about India, for example. And I think you pointed out a really important thing is number one, we don't know that there's any safe level even though blood lead levels in the United States and Europe, for example, have come down by over 95%. The levels that we're exposed to and especially the levels in our bones are 10 to 100 times higher than our pre-industrial ancestors.Bruce Lanphear (05:36):So we haven't yet reached those levels that our ancestors were exposed to. Are there effects at even lower and lower levels? Everything would suggest, we should assume that there is, but we don't know down below, let's say one microgram per deciliter or that's the equivalent of 10 parts per billion of lead and blood. What we also know though is when leaded gasoline was restricted in the United States and Canada and elsewhere, the companies turned to the industrializing countries and started to market it there. And so, we saw first the epidemic of coronary heart disease in the United States, Canada, Europe. Then that's come down over the past 50 years. At the same time, it was rising in low to middle income countries. So today over 95% of the burden of disease from lead including heart disease is found in industrializing countries.Eric Topol (06:34):Right. Now, it's pretty striking, of course. Is it true that airlines fuel is still with lead today?Bruce Lanphear (06:45):Well, not commercial airlines. It's going to be a small single piston aircraft. So for example, when we did a study down around the Santa Clara County Airport, Reid-Hillview, and we can see that the children who live within a half mile of the airport had blood lead levels about 10% higher than children that live further away. And the children who live downwind, 25% higher still. Now, nobody's mapped out the health effects, but one of the things that's particularly troubling about emissions from small aircraft is that the particle size of lead is extraordinarily small, and we know how nanoparticles because they have larger surface area can be more problematic. They also can probably go straight up into the brain or across the pulmonary tissues, and so those small particles we should be particularly worried about. But it's been such a long journey to try to figure out how to get that out of aircraft. It's a problem. The EPA recognized it. They said it's an endangerment, but the industry is still pushing back.Eric Topol (07:55):Yeah, I mean, it's interesting that we still have these problems, and I am going to in a minute ask you what we can do to just eradicate lead as much as possible, but we're not there yet. But one study that seemed to be hard to believe that you cited in the review. A year after a ban leaded fuel in NASCAR races, mortality from coronary heart disease declined significantly in communities near racetracks. Can you talk about that one because it's a little bit like the one you just mentioned with the airports?Bruce Lanphear (08:30):Yeah. Now that study particularly, this was by Alex Hollingsworth, was particularly looking at people over 65. And we're working on a follow-up study that will look at people below 65, but it was quite striking. When NASCAR took lead out of their fuel, he compared the rates of coronary heart disease of people that live nearby compared to a control group populations that live further away. And he did see a pretty striking reduction. One of the things we also want to look at in our follow-up is how quickly does that risk begin to taper off? That's going to be really important in terms of trying to develop a strategy around preventing lead poisoning. How quickly do we expect to see it fall? I think it's probably going to be within 12 to 24 months that we'll see benefits.Eric Topol (09:20):That's interesting because as you show in a really nice graphic in adults, which are the people who would be listening to this podcast. Of course, they ought to be concerned too about children and all and reproductive health. But the point about the skeleton, 95% of the lead is there and the main organs, which we haven't mentioned the kidney and the kidney injury that occurs no less the cardiovascular, the blood pressure elevation. So these are really, and you mentioned not necessarily highlighted in that graphic, but potential cognitive hit as well. You also wrote about how people who have symptoms of abdominal pain, memory impairment, and high blood pressure that's unexplained, maybe they should get a blood level screening. I assume those are easy to get, right?Bruce Lanphear (10:17):Oh yeah, absolutely. You can get those in any hospital, any clinic across the country. We're still struggling with having those available where it's most needed in the industrializing countries, but certainly available here. Now, we don't expect that for most people who have those symptoms, lead poisoning is going to be the cause, right. It'd still be unusual unless you work in an industry, for example, smelting batteries to recycle them. We don't expect it to be real common, and we're not even sure, Eric, whether we should be doing widespread screening. If I looked at this as a population scientist, the real focus should be on identifying the sources. We mostly know where those are here and radically moving it down. Getting rid of the lead service lines, which was such a big part of what President Biden was doing, and it was perfect. For every dollar invested to reduce lead exposure from those lead service lines. Ronnie Levin at Harvard said there'd be a 35-fold return in cost, benefits really, and this has always been true, that reducing lead exposure throughout the past 40 years has always been shown to be amazingly cost beneficial. The problem is operating within a free market health system, even though there's tremendous social benefits, that benefit isn't going to be monetized or privatized. And so, who's going to make those decisions? We hope our government is, but that doesn't always play out.Eric Topol (11:52):Well. What's interesting is, as opposed to the problems we have today that are prominent such as the microplastic, nanoplastics, the air pollution, the forever chemicals, that just keep getting worse, I mean, they are just cumulative. This one, there was tremendous improvement, but it's still not enough. And I guess you're zooming in on the lead lines. That'd be the most important thing to work on today. Another thing that has come up, there's been trials, as you may I'm sure, because all over this field of chelation, there's a trial that was run by the NIH, supported by NH that looked at chelation to prevent coronary disease. Is there any evidence that people who have a problem with lead would benefit from chelation therapy?Bruce Lanphear (12:44):Well, there's two major studies that have been done, and Tony Lamas was in charge of both of them. The first one Trial to Assess Chelation Therapy (TACT) study, it was a randomized controlled trial, not intended specifically to focus on lead, but rather it was to look at sort of this alternative therapy. They found significant benefits about an 18% reduction in subsequent cardiac events. That led to a second study that was just published last year, and it was focused on people who had diabetes. They saw some benefit, but it wasn't significant. So whether that's because there wasn't enough variability and exposure, it's not entirely clear, but we've seen this with lead in IQ deficits in kids where we can show that we can reduce blood lead levels. But ultimately what tends to happen is once you've taken lead out of the blood, some of it's released again from the bone, but you still have all that lead in the bone that's there. You get some of it out, but you're not going to get the bulk of it out.The Lead-Estrogen HypothesisEric Topol (13:47):Right. It's a reservoir that's hard to reckon with. Yeah. Now another thing, you have a Substack that is called Plagues, Pollution & Poverty, and you wrote a really provocative piece in that earlier and April called How Estrogen Keeps Lead - and Heart Attacks - in Check, and basically you got into the lead estrogen hypothesis.Eric Topol (14:10):Can you enlighten us about that?Bruce Lanphear (14:12):Yeah. A lot of the seminal work in this area was done by Ellen Silbergeld, who's a brilliant and somewhat peculiar toxicologist and Ellen for years, I focused on childhood lead exposure, and for years Ellen would tell me, almost demolish me for not studying adults. And because she had found back in 1988 that as women go into menopause, their blood lead levels spike increased by about 30%, and that's where most of our lead is stored is in our bone. And so, as I was thinking about this, it all became clear because blood lead levels in boys and girls is about the same. It's comparable up until menarche, and then girls young women's blood leads fall by about 20%. And they stay 20% lower throughout the reproductive years until menopause. And especially during those first few years around menopause, perimenopause, you see fairly striking increases in the weakening of the bone and blood lead levels.Bruce Lanphear (15:19):So that might very well help to explain why estrogen is protected, because what happens is throughout the reproductive life, women are losing a little bit of lead every month. And estrogen is at its lowest during that time, and that's going to be when blood lead is at its highest because estrogen pushes lead into the bone. Not only that, women lose lead into the developing fetus when they're pregnant. So what Ellen found is that there was less of a spike around menopause for the women that had three or four pregnancies because they had offloaded that into their babies. So all of this, if you put it together, and this is of course in a very short note of it, you can see that lead increases dyslipidemia, it leads to tears in the endothelium of the arterial wall, it's going to increase thrombosis. All of these things that we think of as the classic atherosclerosis. Well, what estrogen does is the opposite of those. It decreases dyslipidemia, it repairs the arterial endothelial wall. So how much of it is that estrogen is protective, and how much is it that it's moving lead out of the system, making it less biologically available?Eric Topol (16:46):Yeah, I know. It's really interesting. Quite provocative. Should be followed up on, for sure. Just getting to you, you're a physician and epidemiologist, MD MPH, and you have spent your career on this sort of thing, right? I mean, is your middle name lead or what do you work on all the time?Bruce Lanphear (17:09):Yeah, I've been doing this for about 30 years, and one of my mentors, Herb Needleman spent 40 years of his career on it. And in some ways, Eric, it seems to me particularly in these very difficult entrenched problems like lead, we don't have any pharmaceutical company reaching out to us to promote what we do. We've got industry trying to squash what we do.Bruce Lanphear (17:35):It really does take a career to really make a dent in this stuff. And in a way, you can look at my trajectory and it is really following up on what Herb Needleman did and what Clare Patterson did, and that was finding the effects at lower and lower levels. Because what we do with lead and most other toxic chemicals, the ones that don't cause cancer, is we assume that there's a safe level or threshold until we prove otherwise. And yet when you look at the evidence, whether it's about asbestos and mesothelioma, air pollution and cardiovascular mortality, lead and cardiovascular mortality, benzene and leukemia, none of those exhibit a threshold. In some cases, the risks are steepest proportionately at the lowest measurable levels, and that really raises some tremendous challenges, right? Because how are we going to bring air pollution or lead down to zero? But at the same time, it also provides these tremendous opportunities because we know that they're causing disease. We know what the sources are. If we could only bring about the political will to address them, we could prevent a lot of death, disease, and disability. I mean, about 20% of deaths around the world every year are from air pollution, lead, and other toxic chemicals, and yet the amount of money we invest in them is just paltry compared to what we invest in other things. Which is not to pit one against the other, but it's to say we haven't invested enough in these.Eric Topol (19:14):No, absolutely. I think your point, just to make sure that it's clear, is that even at low levels, this is of course where most of the population exposure would be, and that's why that's so incriminating. Now, one of the things I just want to end up with is that we know that these are tiny, tiny particles of lead, and then the question is how they can synergize and find particulate matter of air pollution in the nanoplastic, microplastic story and binding to forever chemicals, PFAS. How do you process all that? Because it's not just a single hit here, it's also the fact that there's ability to have binding to the other environmental toxins that are not going away.Bruce Lanphear (20:10):That's right. And in a way, when we talk about lead playing this tremendous role in the rise and decline of coronary heart disease, we can't entirely separate it out, for example, from air pollution or cigarette smoke for that matter, nor plastic. So for example, with air pollution, if we look at air pollution over the past century, up until the 1980s, even into the 1990s, it was leaded, right? So you couldn't separate them. If you look at cigarette smoke, cigarette tobacco in the 1940s and 1950s was grown in fields where they used lead arsenic as an insecticide. So smokers even today have blood lead levels that are 20% higher than non-smokers, and people who are not smokers but exposed to secondhand smoke have blood lead levels 20% higher than non-smokers who aren't exposed to secondhand smoke. So in a way, we should try to tease apart these differences, but it's going to be really challenging. In a way we can almost think about them as a spectrum of exposures. Now with plastics, you can really think of plastics as a form of pollution because it's not just one thing. There's all these additives, whether it's the PFAS chemicals or lead, which is used as a stabilizer. And so, all of them really are kind of integrated into each other, which again, maybe there's some opportunity there if we really were ready to tackle.Eric Topol (21:40):And interestingly, just yesterday, it was announced by the current administration that they're stopping all the prior efforts on the forever chemicals that were initiated in the water supply. And I mean, if there's one takeaway from our discussion, it's that we have to get all over this and we're not paying enough attention to our environmental exposures. You've really highlighted spotlighted the lead story. And obviously there are others that are, instead of getting somewhat better, they're actually going in the opposite direction. And they're all tied together that's what is so striking here, and they all do many bad things to our bodies. So I don't know how, I'm obviously really interested in promoting healthy aging, and unless we get on this, we're chasing our tails, right?Bruce Lanphear (22:31):Well, I think that's right, Eric. And I was reading the tips that you'd written about in preparation for your book release, and you focused understandably on what each of us can do, how we can modify our own lifestyles. We almost need six tips about what our government should do in order to make it harder for us to become sick, or to encourage those healthy behaviors that you talked about. That's a big part of it as well. One of the things we're celebrating the hundredth anniversary. This is not really something to celebrate, but we are. The hundredth anniversary of the addition of tetraethyl lead to gasoline. And one of the key things about that addition, there was this debate because when it was being manufactured, 80% of the workers at a plant in New Jersey suffered from severe lead poisoning, and five died, and it was enough that New York City, Philadelphia and New Jersey banned tetraethyl lead.Bruce Lanphear (23:31):Then there was this convening by the US Surgeon General to determine whether it was safe to add tetraethyl lead to gasoline. One scientist, Yandell Henderson said, absolutely not. You're going to create a scourge worse than tuberculosis with slow lead poisoning and hardening of your arteries. Robert Kehoe, who represented the industry said, we know lead is toxic, but until you've shown that it's toxic when added to gasoline, you have no right to prohibit us from using it. So that is now known as the Kehoe rule, and it's relevant not only for lead, but for PFAS, for air pollution, for all these other things, because what it set as a precedent, until you've shown that these chemicals or pollution is toxic when used in commerce, you have no right to prohibit industry from using it. And that's the fix we're in.Eric Topol (24:27):Well, it sounds too much like the tobacco story and so many other things that were missed opportunities to promote public health. Now, is Canada doing any better than us on this stuff?Bruce Lanphear (24:40):In some ways, but not in others. And one of the interesting thing is we don't have standards, we have guidelines. And amazingly, the cities generally try to conform to those guidance levels. With water lead, we're down to five parts per billion. The US is sticking around with ten parts per billion, but it's not even really very, it's not enforced very well. So we are doing better in some ways, not so good in other ways. The European Union, generally speaking, is doing much better than North America.Eric Topol (25:15):Yeah, well, it doesn't look very encouraging at the moment, but hopefully someday we'll get there. Bruce, this has been a really fascinating discussion. I think we all should be thankful to you for dedicating your career to a topic that a lot of us are not up on, and you hopefully are getting us all into a state of awareness. And congratulations on that review, which was masterful and keep up the great work. Thank you.Bruce Lanphear (25:42):Thank you, Eric. I appreciate it.________________________________________________My Recommendations for Preventing Heart Disease (Markedly Truncated from Text and Graphics Provided in SUPER AGERS)Recently the Washington Post asked me for a listicle of 10 ways to prevent heart disease. I generally avoid making such lists but many people have de-subscribed to this newspaper, never subscribed, or missed the post, so here it is with links to citations:Guest column by Eric Topol, MDThe buildup of cholesterol and other substances in the wall of our arteries, known as atherosclerosis, is common. It can lead to severe plaques that narrow the artery and limit blood flow, or to a crack in the artery wall that can trigger blood clot formation, resulting in a heart attack.While we've seen some major advances in treating heart disease, it remains the leading killer in the United States, even though about 80 percent of cases are considered preventable. There are evidence-based steps you can take to stave it off. As a cardiologist, here's what I recommend to my patients.1. Do both aerobic and resistance exerciseThis is considered the single most effective medical intervention to protect against atherosclerosis and promote healthy aging. Physical activity lowers inflammation in the body. Evidence has shown that both aerobic and strength training forms of exercise are important. But only 1 in 4 Americans meet the two activity guidelines from the American Heart Association: aerobic exercise of 150 minutes per week of at least moderate physical activity, such as walking, bicycling on level ground, dancing or gardening, and strength training for at least two sessions per week, which typically translates to 60 minutes weekly.The protective benefit of exercise is seen with even relatively low levels of activity, such as around 2,500 steps per day (via sustained physical activity, not starting and stopping), and generally increases proportionately with more activity. It used to be thought that people who exercise only on the weekend — known as “weekend warriors” — put themselves in danger, but recent data shows the benefits of exercise can be derived from weekend-only workouts, too.2. Follow an anti-inflammatory dietA predominantly plant-based diet — high in fiber and rich in vegetables, fruits and whole grains, as seen with the Mediterranean diet — has considerable evidence from large-scale observational and randomized trials for reducing body-wide inflammation and improving cardiovascular outcomes.Foods rich in omega-3 fatty acids, such as salmon, also form part of a diet that suppresses inflammation. On the other hand, red meat and ultra-processed foods are pro-inflammatory, and you should limit your consumption. High protein intake of more than 1.4 grams per kilogram of body weight per day — around 95 grams for someone who is 150 pounds — has also been linked to promoting inflammation and to atherosclerosis in experimental models. That is particularly related to animal-based proteins and the role of leucine, an essential amino acid that is obtained only by diet.3. Maintain a healthy weightBeing overweight or obese indicates an excess of white adipose tissue. This kind of tissue can increase the risk of heart disease because it stores fat cells, known as adipocytes, which release substances that contribute to inflammation.In studies, we've seen that glucagon-like peptide (GLP-1) drugs can reduce inflammation with weight loss, and a significant reduction of heart attacks and strokes among high-risk patients treated for obesity. Lean body weight also helps protect against atrial fibrillation, the most common heart rhythm abnormality.4. Know and avoid metabolic syndrome and prediabetesTied into obesity, in part, is the problem of insulin resistance and metabolic syndrome. Two out of three people with obesity have this syndrome, which is defined as having three out of five features: high fasting blood glucose, high fasting triglycerides, high blood pressure, low high-density lipoprotein (HDL) and central adiposity (waist circumference of more than 40 inches in men, 35 inches in women).Metabolic syndrome is also present in a high proportion of people without obesity, about 50 million Americans. Prediabetes often overlaps with it. Prediabetes is defined as a hemoglobin A1c (a measure of how much glucose is stuck to your red blood cells) between 5.7 and 6.4 percent, or a fasting glucose between 100 and 125 milligrams per deciliter.Both metabolic syndrome and prediabetes carry an increased risk of heart disease and can be prevented — and countered — by weight loss, exercise and an optimal diet.As the glucagon-like peptide drug family moves to pills and less expense in the future, these medications may prove helpful for reducing risk in people with metabolic syndrome and prediabetes. For those with Type 2 diabetes, the goal is optimizing glucose management and maximal attention to lifestyle factors.5. Keep your blood pressure in a healthy rangeHypertension is an important risk factor for heart disease and is exceptionally common as we age. The optimal blood pressure is 120/80 mm Hg or lower. But with aging, there is often an elevation of systolic blood pressure to about 130 mm Hg, related to stiffening of arteries. While common, it is still considered elevated.Ideally, everyone should monitor their blood pressure with a home device to make sure they haven't developed hypertension. A mild abnormality of blood pressure will typically improve with lifestyle changes, but more substantial elevations will probably require medications.6. Find out your genetic riskWe now have the means of determining your genetic risk of coronary artery disease with what is known as a polygenic risk score, derived from a gene chip. The term polygenic refers to hundreds of DNA variants in the genome that are linked to risk of heart disease. This is very different from a family history, because we're a product of both our mother's and father's genomes, and the way the DNA variants come together in each of us can vary considerably for combinations of variants.That means you could have high or low risk for heart disease that is different from your familial pattern. People with a high polygenic risk score benefit the most from medications to lower cholesterol, such as statins. A polygenic risk score can be obtained from a number of commercial companies, though it isn't typically covered by insurance.I don't recommend getting a calcium score of your coronary arteries via a computed tomography (CT) scan. This test is overused and often induces overwhelming anxiety in patients with a high calcium score but without symptoms or bona fide risk. If you have symptoms suggestive of coronary artery disease, such as chest discomfort with exercise, then a CT angiogram may be helpful to map the coronary arteries. It is much more informative than a calcium score.7. Check your blood lipidsThe main lipid abnormality that requires attention is low-density cholesterol (LDL), which is often high and for people with increased risk of heart disease should certainly be addressed. While lifestyle improvements can help, significant elevation typically requires medications such as a statin; ezetimibe; bempedoic acid; or injectables such as evolocumab (Repatha), alirocumab (Praluent) or inclisiran (Leqvio). The higher the risk, the more aggressive LDL lowering may be considered.It should be noted that the use of potent statins, such as rosuvastatin or atorvastatin, especially at high doses, is linked to inducing glucose intolerance and risk of Type 2 diabetes. While this is not a common side effect, it requires attention since it is often missed from lack of awareness.A low high-density lipoprotein (HDL) cholesterol often responds to weight loss and exercise. We used to think that high HDL was indicative of “good cholesterol,” but more recent evidence suggests that is not the case and it may reflect increased risk when very high.To get a comprehensive assessment of risk via your blood lipids, it's important to get the apolipoprotein B (apoB) test at least once because about 20 percent of people have normal LDL and a high apoB.Like low HDL, high fasting triglycerides may indicate insulin resistance as part of the metabolic syndrome and will often respond to lifestyle factors.The lipoprotein known as Lp(a) should also be assessed at least once because it indicates risk when elevated. The good news is scientists are on the cusp of finally having medications to lower it, with five different drugs in late-stage clinical trials.8. Reduce exposure to environmental pollutantsIn recent years, we've learned a lot about the substantial pro-inflammatory effects of air pollution, microplastics and forever chemicals, all of which have been linked to a higher risk of heart disease. In one study, microplastics or nanoplastics in the artery wall were found in about 60 percent of more than 300 people. Researchers found a vicious inflammatory response around the plastics, and a four- to fivefold risk of heart attacks or strokes during three years of follow-up.While we need policy changes to address these toxic substances in the environment, risk can be reduced by paying attention to air and water quality using filtration or purification devices, less use of plastic water bottles and plastic storage, and, in general, being much more aware and wary of our pervasive use of plastics.9. Don't smoke This point, it should be well known that cigarette smoking is a potent risk factor for coronary artery disease and should be completely avoided.10. Get Good SleepAlthough we tend to connect sleep health with brain and cognitive function, there's evidence that sleep regularity and quality are associated with less risk of heart disease. Regularity means adhering to a routine schedule as much as possible, and its benefit may be due to our body's preference for maintaining its circadian rhythm. Sleep quality — meaning with fewer interruptions — and maximal deep sleep can be tracked with smartwatches, fitness bands, rings or mattress sensors.Sleep apnea, when breathing stops and starts during sleep, is fairly common and often unsuspected. So if you're having trouble sleeping or you snore loudly, talk to your doctor about ruling out the condition. Testing for sleep apnea can involve checking for good oxygen saturation throughout one's sleep. That can be done through a sleep study or at home using rings or smartwatches that include oxygen saturation in their sensors and body movement algorithms that pick up disturbed breathing.Eric Topol, MD, is a cardiologist, professor and executive vice president of Scripps Research in San Diego. He is the author of “Super Agers: An Evidence-Based Approach to Longevity” and the author of Ground Truths on Substack.*********************°°°°°°°°°°°°°°°°°°°°Thanks to many of you Ground Truths subscribers who helped put SUPER AGERS on the NYT bestseller list for 4 weeks.Here are 2 recent, informative, and fun conversations I had on the topicMichael Shermer, The SkepticRuss Roberts, EconTalk I'm also very appreciative for your reading and subscribing to Ground Truths.If you found this interesting PLEASE share it!That makes the work involved in putting these together especially worthwhile.All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Let me know topics that you would like to see covered.Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past three years. Just a week ago we just had nearly 50 interns (high school, college and medical students) present posters of the work they did over the summer and it was exhilarating! Some photos below Get full access to Ground Truths at erictopol.substack.com/subscribe

  Woke By Accident- Sambaza Podcast Collaboration Episode Details Guests: Sambaza (Host, Sambaza Podcast) In this powerful and personal episode of Woke By Accident, hosts Jen and Sambaza open up about their individual journeys with weight loss & A1C management. Sambaza's Content https://podcasts.apple.com/us/podcast/sambaza/id1520678096 https://www.instagram.com/sambazapodcast/ Sambaza Affirmation Being me is how I win. The African proverb  Beautiful words don't put porridge in the pot. Podcast Information Website: www.wokebyaccident.net Streaming Platforms: Available on all your favorite streaming platforms Sponsors Poddecks: https://www.poddecks.com?sca_ref=1435240.q14fIixEGL Affiliates Buddys Pet Referral Link: 30% discount https://buddyspet.net/?ref=JENSBUDDY Opus Clips: https://www.opus.pro/?via=79b446 StreamYard: https://streamyard.com/pal/d/5989489347657728 Curtsy: Use code JEND87 for $10 off first order of $20 or more https://heycurtsy.com/BLN7Be4kUzb Whatnot: https://whatnot.com/invite/jendub Poshmark: https://posh.mk/bDYu5ZMwbTb (Receive $10 to shop using this code) Music Soul Searching · Causmic Last Night's Dream — Tryezz Funkadelic Euphony- Monz    

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.What does it take to climb some of the world's tallest peaks while managing Type 1 diabetes? In this episode, I sit down with mountaineer and T1D veteran Luis Freitas, who has lived with diabetes since the age of two. Luis shares the highs, lows, and lessons from 28 years of managing diabetes—including his solo attempt to summit the tallest mountain in South America. We explore the mental toughness needed to thrive with diabetes, the truth about A1C obsession, and why defining your own version of health is key to long-term success.Key TakeawaysAcceptance is a superpower — Why embracing both the condition and inevitable setbacks can transform your mindset.Your health, your rules — How Luis defines acceptable blood sugars for high-altitude climbs without sacrificing safety.The limits of A1C — Why chasing a perfect number can damage your mental health and how to focus on what truly matters.Bullying, community, and identity — How early experiences shaped Luis's relationship with diabetes and why community is essential.Do hard things — How pushing beyond your comfort zone builds resilience, both on the mountain and in daily life with T1D.Resources & Links Mentioned in This Episode

 Today on Beating Cancer Daily, Saranne brings her signature warmth and wisdom to an engaging exploration of the pancreas, focusing on its essential and often overlooked impact on health, particularly during and after cancer treatment. As a Stage IV cancer survivor, Saranne reflects on her journey to better health by nurturing each organ individually, placing special emphasis on the pancreas as a foundation for surviving intense therapies. Saranne is joined by the much-loved Jacqui Bryan, who shares expert advice on nutrition and practical steps for optimizing pancreas health. Their discussion reveals surprising facts about the pancreas, its multiple functions, what can threaten its wellness, and the proactive lifestyle adjustments anyone can make to support this crucial organ. Jacqui Bryan is a certified nutrition specialist, functional medicine expert, whole health educator, registered nurse, and a 22-year cancer survivor. Her broad expertise and empathetic style have inspired listeners to embrace healthier habits and empowered countless individuals to understand and care for their bodies through evidence-based nutrition and holistic strategies. “Our job is to make it easier for our body, not more challenging.” ~Jacqui Bryan Today on Beating Cancer Daily:·     The pancreas is involved in both digestion and blood sugar regulation, making it essential to overall health for everyone.·     Inflammation or damage to the pancreas can cause serious conditions like pancreatitis, diabetes, and malnutrition.·     Choosing nutrient-dense foods and reducing sugar, processed foods, and alcohol can lower the burden on the pancreas.·     Consuming antioxidants, fiber, omega-3 fatty acids, magnesium, and B vitamins supports pancreatic strength and resilience.·     Lifestyle changes such as adequate hydration, regular physical activity, and stress management help protect the pancreas.·     Regular checkups and blood sugar monitoring, including the A1C test, are important for tracking pancreatic and whole-body health.·     Certain medications, viral infections, genetics, and abdominal trauma can raise the risk of pancreatic issues.·     Small changes, such as habit stacking, mindful fiber intake, and eating a colorful variety of plant foods, can make a significant impact on pancreatic and overall wellness. Guest Contact InformationJacqui Bryan Website 2025 People's Choice Podcast Awards Finalist Ranked the Top 5 Best Cancer Podcasts by CancerCare News in 2024 & 2025, and #1 Rated Cancer Survivor Podcast by FeedSpot in 2024 Beating Cancer Daily is listened to in over 130 countries across 7 continents and features over 390 original daily episodes hosted by Stage IV survivor  Saranne Rothberg.   To learn more about Host Saranne Rothberg and The ComedyCures Foundation:https://www.comedycures.org/ To write to Saranne or a guest:https://www.comedycures.org/contact-8 To record a message to Saranne or a guest:https://www.speakpipe.com/BCD_Comments_Suggestions To sign up for the free Health Builder Series live on Zoom with Saranne and Jacqui, go to The ComedyCures Foundation's homepage:https://www.comedycures.org/ Please support the creation of more original episodes of Beating Cancer Daily and other free ComedyCures Foundation programs with a tax-deductible contribution:http://bit.ly/ComedyCuresDonate THANK YOU! Please tell a friend whom we may help, and please support us with a beautiful review. Have a blessed day! Saranne

Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Today, we're diving into one of the most talked-about topics in health and weight loss right now: GLP-1 medications like semaglutide and the newer dual GIP/GLP-1s like tirzepatide. You've probably seen the headlines, scrolled past a few TikToks, or heard a friend mention it — but with all that noise comes a lot of confusion, half-truths, and flat-out myths. Today we're breaking it all down. What's real? What's hype? And what do you actually need to know if you're using these medications — or thinking about it? Let's separate science from scare tactics and get to the truth, one myth at a time. Myth #1: GLP-1s Cause Dangerous Muscle Loss The claim:  “GLP-1s cause massive muscle loss.” Truth: This is an overstatement. Some loss of lean mass is normal with any kind of weight loss — whether it's through diet, medication, or surgery. What studies show is that with medications like semaglutide (Wegovy) and tirzepatide (Zepbound), about 20–25% of the total weight lost comes from lean mass, and the rest is fat — which is exactly what we're targeting in obesity treatment. That 20–25% figure isn't unique to these meds; it's actually pretty typical in weight loss without focused resistance training or optimized protein intake. You may also hear “You'll lose all your muscle and become frail on GLP-1s.” Truth: You won't “lose all your muscle.” In fact, muscle loss is preventable by maintaining adequate protein intake, resistance training, and managing weight loss pace. Furthermore, many patients gain strength and mobility as excess weight comes off. And lastly, my favorite myth is “You can't preserve muscle on GLP-1s.” Truth: That's completely false — muscle loss isn't inevitable on GLP-1s if you take the right approach. You can absolutely preserve muscle by making a few intentional choices: aim for enough protein each day (a good goal is around 0.8 grams per pound of body weight), include some strength or resistance training a couple times a week, and avoid losing weight too quickly. These simple steps go a long way in protecting your lean mass while still getting all the benefits of weight loss. One study on semaglutide showed that people lost an average of about 15% of their body weight, and only around 3–4% of that was lean mass. So if someone drops 30 pounds, maybe 6 to 8 of those pounds might be lean mass—not ideal, but definitely not disastrous either, and very manageable with the right lifestyle habits.  The truth is, while some lean mass loss is expected with any type of weight loss, research shows that most of the weight lost on GLP-1s is actually fat, not muscle. For example, in the STEP 1 trial, about 80% of the weight lost on semaglutide came from fat, and only about 20% from lean tissue (as we mentioned earlier).  The SURMOUNT-1 trial with tirzepatide showed similar results—significant fat loss with relatively preserved muscle, especially when paired with resistance training. And that's important, because preserving muscle during weight loss helps protect metabolism, strength, and overall health. With good nutrition and movement, GLP-1s can lead to healthier body composition—not just a lower number on the scale. Okay, moving along to the next myth … Myth #2: GLP-1s Can Cause Blindness The truth: This myth stems from concerns about diabetic retinopathy worsening, which is tied to how quickly blood sugar drops, not to the drug itself. In the SUSTAIN-6 trial (Marso et al., NEJM, 2016), a small subset of patients with pre-existing advanced diabetic retinopathy saw transient worsening—but only in those with rapid improvements in A1c. No increased rates of blindness or new-onset retinopathy have been found in non-diabetic patients using GLP-1s for weight loss. The bottom line is that those without advanced diabetic eye disease, there's no increased risk of blindness. Patients with diabetic retinopathy should be monitored closely—but this is about glycemic management, not a direct effect of the medication. Myth #3: GLP-1s Cause Kidney or Liver Damage The truth: This is false. In fact, GLP-1 agonists may protect kidney and liver function—especially in patients with diabetes or fatty liver disease. The most recent notable study showing kidney‑protective effects of a GLP‑1 receptor agonist is the FLOW trial, which evaluated semaglutide in people with type 2 diabetes and chronic kidney disease (CKD). This double‑blind, randomized, placebo‑controlled trial included 3,533 participants followed for a median of 3.4 years and found that semaglutide reduced the risk of major kidney‑related events—including kidney failure, substantial eGFR decline, and death from renal or cardiovascular causes—by 24% compared to placebo. A 2025 meta-analysis of multiple randomized controlled trials (11 studies, 85,373 participants) concluded that GLP‑1 receptor agonists reduced the risk of composite kidney failure outcomes by 18%, kidney failure by 16%, and all‑cause death by 12%. And let's not forget the SMART trial, involving obese patients with kidney disease but without diabetes, found that semaglutide protected kidney function in this non‑diabetic, CKD‑affected population.  When it comes to the liver, there's actually growing evidence they're actually helping reverse non-alcoholic fatty liver disease (NAFLD). The STEP 1 MRI substudy and SURPASS-3 MRI substudy have shown people on these medications can reduce liver fat by 30 to even 50% and in some cases, completely resolve liver inflammation — that more serious form called NASH, where fat is combined with inflammation and early scarring. The LEAN trial found that nearly 60% of people taking semaglutide had resolution of NASH, without worsening their liver scarring. That's huge. And even better, we're seeing these effects even in people who don't have diabetes. Just losing weight helps fatty liver, but these meds seem to do more than that — they actually target inflammation and fat storage in the liver itself.. The bottom line is GLP-1s are not nephrotoxic or hepatotoxic. In fact, they may be organ-protective—especially for people with underlying metabolic issues. Myth #4: These Drugs Lead to Bone Loss The claim: “You'll get osteoporosis from losing too much weight!” The truth: While extreme weight loss can affect bone density, GLP-1s themselves do not cause bone loss, and may even have neutral or protective effects on bone. A 2022 study in Bone found no significant change in BMD (bone mineral density) in adults treated with semaglutide for obesity. While the SUSTAIN and PIONEER programs found no increased risk of fractures in semaglutide-treated patients versus placebo. Truly, concerns about bone loss are more relevant in extreme calorie restriction or eating disorders—not evidence-based GLP-1 treatment with appropriate nutrition. Myth #5: Everyone Gets Gastroparesis The claim: “These medications paralyze your stomach” The truth: GLP-1s slow gastric emptying, which is part of how they work—making you feel full longer. But this is dose-dependent and typically reversible. A 2023 FDA safety review found that true gastroparesis is extremely rare and resolves when the drug is stopped. Reality check: Nausea, early satiety, and mild bloating are common but manageable side effects. True, lasting gastroparesis is not typical, especially when doses are titrated gradually. Myth #6: GLP-1s Make Your Hair Fall Out The claim: “You'll lose a ton of hair—just like with crash diets” The truth: Hair shedding is not directly caused by GLP-1 medications. Instead, it's often a temporary, non-scarring condition called telogen effluvium, which can happen with any rapid weight loss, regardless of the method. A 2023 analysis from the American Academy of Dermatology emphasized that telogen effluvium is common with surgical or medical weight loss, especially if patients lose more than 10% of their body weight within a few months. In clinical trials like STEP and SURMOUNT, hair loss was not listed as a common side effect, but patient-reported data show it occurs occasionally—likely tied to nutritional stress, not the drug itself. So why does hair loss happen? We've talked about this before, but I don't want to leave this important information out.  Hair follicles are sensitive to internal stress. Rapid changes in caloric intake, nutrient levels (like iron, zinc, and biotin), or hormone balance can push hairs into the shedding phase. This is a delayed effect, often showing up 2–3 months after weight loss begins, and it typically resolves within 6–12 months. What helps is slower, sustained weight loss, prioritizing protein intake, supplementing iron, zinc, and biotin if deficient, and avoiding very low-calorie diets and over-restriction. Myth #6: GLP-1s Cause Dehydration It's a common myth that GLP-1 medications cause dehydration — but that's not exactly true. The medication itself doesn't directly dehydrate you. What can happen is that some people experience nausea, vomiting, or a reduced appetite early on, which can lead to drinking less water without realizing it. That's where the dehydration risk comes in. A good general rule for staying hydrated is to aim for half your body weight in ounces of water per day. So, for example, if you weigh 160 pounds, try to drink around 80 ounces daily — more if you're active or live in a hot climate. Electrolytes can also be really helpful, especially if you're feeling tired, dizzy, or crampy. I like LMNT packets — they're a clean option with no sugar and a good balance of sodium, magnesium, and potassium. The sodium in LMNT packets helps keep you hydrated by pulling water into your cells and helping your body retain the fluids it needs to function properly. Just one a day can make a big difference in how you feel. Myth #7: You Have to Stay on GLP-1s Forever or You'll Gain All the Weight Back The claim: “As soon as you stop taking it, all the weight comes back” The truth: Yes—some weight regain is likely after stopping GLP-1 medications. But that doesn't mean they're ineffective or that you're doomed to rebound completely. The same pattern happens after any type of weight loss intervention, whether it's a diet, surgery, or medication. The STEP 4 trial (Wilding et al., 2022) showed that participants who stopped semaglutide after 20 weeks regained an average of 6% of their weight loss over the next year. But it's important to note that they still weighed less than at baseline—and many continued to experience improvements in blood pressure, cholesterol, and insulin sensitivity. Similarly, in SURMOUNT-4, patients who stopped tirzepatide also regained weight, but less than they lost. So why does this weight gain happen? I feel like the answer to this is obvious, but I've found that it's not.  GLP-1s change your appetite and hunger cues. Once the medication is stopped, your body's baseline hunger signals return—and often with increased intensity, due to metabolic adaptation. But this isn't unique to GLP-1s. The same thing happens after crash diets, keto, intermittent fasting, or bariatric surgery if long-term changes aren't made. The real issue isn't the drug—it's the lack of a plan after the drug. To help make results sustainable, we need to use the medication as a tool, not a crutch. We should use it to help us lose weight and understand our hunger cues, while transitioning to a whole foods, protein based diet coupled with resistance training to help preserve and build muscle.  Just remember, if you're coming off a GLP-1 and want to keep the momentum going, the key is to approach it thoughtfully. Tapering slowly under medical supervision can help your body adjust and reduce the chances of weight regain. At the same time, this is a great moment to double down on the habits that helped you feel your best while on the medication. Think ongoing support—like working with a health coach, joining a support group, or even doing behavioral therapy—to help reinforce those long-term lifestyle changes. It's not just about what you stop; it's about what you keep doing that matters most. You don't necessarily have to stay on GLP-1s forever—but if you stop without a plan, some weight regain is very likely. Think of them like glasses: they help you see clearly while you build the habits to eventually navigate without them. For some, that may mean staying on a lower maintenance dose long-term—just like with blood pressure or cholesterol meds. What are my final thoughts? I want to be clear—GLP-1s aren't magic. But they are powerful tools when paired with education, support, and smart lifestyle changes.  Myths like ‘you'll go blind,' ‘you'll lose all your hair,' or ‘you'll be stuck on these meds forever' aren't just misleading and downright false—they discourage people from getting real help.  So if you're thinking about these medications, get informed, ask the hard questions, and make your decision based on science—not fear. Thank you for listening to The Peptide Podcast. If you enjoyed the show and want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  Until next time, be well, and as always, have a happy, healthy week.

Feeling confused by all the conflicting advice on how to manage your type 2 diabetes or prediabetes? You're not alone. In this episode we tackle the very real problem of information overload, why it happens, how it can derail your progress, and what you can do to finally cut through the noise.You'll learn how to spot reliable, evidence-based advice, avoid getting sidetracked by extreme claims or shiny new trends, and stay focused on a few core habits that actually work. You'll discover practical tips, quality indicators to look for, and real success stories from people just like you who've moved past confusion and started seeing real results.If you're tired of spinning in circles and ready to simplify your approach so you can lower your blood sugar, improve your A1c, and feel better for the long term, this episode is for you. For show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe

On today's episode, Dr. Mark Costes sits down with Dr. David Reznik, a pioneering force in public health dentistry and founder of the HIV Dental Alliance. Speaking from the Exhibitor Hall at Thrive Live in Las Vegas, Dr. Reznik shares his decades-long journey in treating HIV-positive patients, his role in establishing the Oral Health Center at Grady Health System, and the critical need for proper infection control in dental offices.   He dives into topics from waterline safety protocols and hemoglobin A1C testing to post-exposure prophylaxis and advances in HIV treatment. With over 6,000 HIV patients in care and a leadership role in training the next generation of dentists through NYU Langone's AEGD program, Dr. Reznik brings both clinical expertise and heartfelt advocacy to a conversation every dentist should hear. Be sure to check out the full episode from the Dentalpreneur Podcast! EPISODE RESOURCES linkedin.com/in/david-reznik-ab83522 https://www.truedentalsuccess.com Dental Success Network Subscribe to The Dentalpreneur Podcast

Broadcast from KSQD, Santa Cruz on 8-07-2025: Dr. Dawn opens with groundbreaking news about the first successful islet cell transplant for type 1 diabetes without immunosuppression. A 42-year-old man received gene-edited donor cells that were modified to avoid immune rejection by removing tissue compatibility markers and adding protective proteins. The transplanted cells in his forearm began producing insulin autonomously, reducing his A1C by 42% over 12 weeks. This breakthrough could lead to off-the-shelf diabetes treatments without the cancer and infection risks of immunosuppressive drugs. She critiques a case where a patient was prescribed an expensive new osteoporosis drug without trying conservative treatments first. Dr. Dawn explains how this monoclonal antibody works by blocking sclerostin, essentially cutting the brake lines on bone formation. While effective for severe osteoporosis, the drug increases heart attack and stroke risk by 15%. She advocates for trying lifestyle changes, exercise, and established treatments before resorting to newer, more dangerous medications with questionable risk-benefit ratios. A caller asks about a pustular rash on his upper body that his acupuncturist suggests might be related to COVID vaccination. Dr. Dawn addresses the distribution pattern of the rash, suggesting possible causes like hot tub folliculitis or topical allergies based on the location. She discusses how to evaluate rashes by their characteristics and distribution rather than jumping to vaccine-related conclusions. The caller inquires about vaccine development timelines and whether rushed approval during COVID might have missed serious side effects. Dr. Dawn explains that mRNA vaccine technology existed for 10 years before COVID and discusses her theory about vaccine side effects. She describes how spike proteins may temporarily deplete anti-inflammatory mechanisms, leading to flare-ups of existing conditions like eczema or arthritis, but emphasizes these effects are generally temporary and rebuilding occurs over time. Caller asks about RFK Jr.'s stance on vaccine research and the long-term implications of reducing vaccine development. Dr. Dawn provides a nuanced response about problems with the current vaccine system, including government-guaranteed markets that incentivize overproduction of vaccines. She discusses the evolution from essential vaccines for devastating diseases to newer vaccines for less critical conditions, explaining the economic forces that drive development and the resulting over-vaccination in healthy populations versus the need to protect vulnerable individuals. Dr. Dawn concludes with an innovative medical technology - a robot mattress designed to prevent pressure ulcers in immobilized patients. The mattress contains 1,260 independently controlled pistons that create undulating checkerboard patterns, alternating pressure points to stimulate blood flow. Research showed that brief high pressure followed by relief works better than constant low pressure, reducing pressure ulcer areas by 34 times compared to standard foam padding.

In this episode, Brent sits down with Dr. Richard Maurer, a naturopathic doctor and author of The Blood Code, a book about metabolic health. They discuss markers like A1C, LDL, HDL, triglycerides, and how these impact risks for conditions such as diabetes and heart disease. Dr. Maurer shares his personal journey of reversing prediabetes and provides actionable insights on diet, exercise, and maintaining a balance between endurance and weight training to optimize health. The conversation then shifts to Dr. Maurer's approach to his Parkinson's diagnosis. With a focus on information, community, and proactive measures, he details how he has adapted his lifestyle to slow the progression of this neurodegenerative disease. Hope you enjoy.

Hello, we're Elaine and Julian Walker. We're American expats. We are currently living in Japan again, this time in northern Japan.  We've been doing intermittent fasting since mid-March of 2018. My husband was already looking at some health videos by Thomas Delauer, but I never really caught on to it.  After moving to Japan in 2017, I knew I wanted to improve my health, but I lacked a strategy.  It wasn't until I went in to get a dental cleaning done that I was told that I had high blood pressure. They could do the cleaning, but not give me a cavity filling.  That led me to see a doctor, and I was told that I had hypertension. I immediately went home and started looking at health videos, which led me to Dr. Eric Berg.  We credit him for introducing keto and intermittent fasting to us and additionally, gaining more knowledge on artery health, vitamin information, and especially the importance of vitamin D3 and K2.  Three days after that doctor's appointment, I started IF and keto. Nine days after that, my blood pressure started going down, and I was able to wear my wedding band again.  My highest weight was 278. Julian saw that I wanted to skip a meal that first day, and he started IF with me.  When we last spoke to you, we were living in Hawaii for a couple of years. My husband's government job has a consecutive time limit on how long we can live in Japan.  We never stopped doing IF, but we both were having window creep, eating fast food and the standard American diet a bit more. We strayed away from keto and carnivore. We've been back in Japan since August 2024.  Julian arranged for us to see a military base doctor so that we could assess our health. On October 10th, the doctor called Julian at night, saying that his A1c was very high. And my weight had bounced up to 215 pounds. The next day, we kicked things back into gear. Julian wanted to go strict carnivore, and that's where we've been since October. The carnivore diet has reduced visceral fat, improved our A1c markers, and resolved our fatty liver. I am now down to 170, which is less than my high school weight. Julian has lost more than 30 pounds. I have tips, such as:- Prioritise protein when you open your eating window. - workout fasted- Limit and remove bad oils- Trace minerals and electrolytes are very important. To join the Patreon Community. Please go to www.patreon.com/thefastinghighway or visit the website www.thefastinghighway.com for more information.NEW-Graeme's Breaking Free From Sugar Club is an added Benefit for Patreon Members with two hours of group support a month Via Zoom to help you break free from Sugar. This is in addition to four weekly Zoom Support meetings held each month at convenient times worldwide.To book a one-on-one support session with GraemePlease go to the website, click " get help" and " get coaching " to book a time. www.thefastinghighway.comDisclaimerThe views expressed in this podcast are those of the host and guest only and should not be taken as medical advice.

An episode from The Holistic Navigator. This is not to diagnosis or treat any disease/illness. Consult your physician before taking supplements or medications OR before you stop taking medications. This is for entertainment/informational purposes only! Just as a refresher, diabetes is a disease that can cause blood glucose to stay in the bloodstream for prolonged periods. Our bodies secrete a hormone called insulin from our pancreas, which helps glucose be used for energy. When diabetes comes into play, our bodies don't use insulin correctly resulting in increased blood glucose levels in the bloodstream. This can lead to cardiovascular complications, glaucoma, nerve damage and even limb amputation. It's serious stuff that affects nearly half of the American adult population according to the American Diabetes Association. On this week's episode we want to address a few of the consistent questions we've been getting about this issue. There are measures that can be taken early on to help limit your possibility of developing diabetes, mainly stemming from a diet, nutrition, and supplementation perspective. Ed talks about why American diagnoses of diabetes are increasing, the typical problem areas that can be addressed naturally, and basic supplements that can help restore optimal health. Some Topics We Discussed: What is a diagnosis of type 2 diabetes? (6:08) What can impact your A1C levels? (6:45) What are ideal blood sugar levels? (8:59) What are the negative effects of elevated insulin levels? (13:17) What would Ed do if he was diagnosed as pre-diabetic? (14:55) What is the appropriate amount of protein to consume? (24:07) This podcast is powered by ZenCast.fm

What is sarcopenia and why is this such an important topic for every woman over 40?  That is the topic of conversation today.  What is Sarcopoenia? Sarcopenia is to muscle what osteoporosis is to bone.  Significant loss of skeletal muscle mass and or muscle strength. Sarcopenia is tied to anabolic resistance in midlife women, making it harder to gain lean muscle growth or maintenance after 40. Older adults - both men and women - have to work harder to gain lean muscle mass.  Women have less overall body mass and muscle to begin with and more dramatic reductions in estrogen at menopause, than men experience loss of testosterone.  The key stimulus for muscle protein synthesis, will suffer more from loss of strength and mass if they aren't carefully offsetting it with planned and progressive resistance training.  For women, estrogen protects muscle and bone. We need and use testosterone which is the most abundant hormone in the female body - but it's the decline in estrogen that makes the difference in muscle preservation. What Contributes to Sarcopenia?  Malnutrition. Combined with sarcopenia, it's a predictor of all-cause mortality than sarcopenia alone.  The United States is one of the most overfed and undernourished countries in the world. We're not eating well enough to sustain health.  Sarcopenia is 100% avoidable.  How Do You Measure Sarcopenia? Strength Fat free mass and height Online calculators  There are physical tests or measures that include grip strength or calf circumference.  Women didn't measure or track their skeletal muscle mass decades ago to know where it was at peak. It's harder to say how much mass or strength you've lost.  The Surprising Statistics on What is Sarcopenia On average, muscle loss occurs 3-8% each decade starting at 30. That CAN accelerate during menopause transition. It isn't associated with loss of estrogen driving skeletal muscle protein synthesis down. It's the side effects of the decline of estrogen.  Not sleeping. Struggle exercising as hard or as long  Less support for your muscle from testosterone and growth hormone  Have cortisol, ghrelin and leptin hormone dysregulation that interferes with muscle and fat. We do have the ability to regain lean muscle.  It's proven (and shared in prior episodes) that 85+ individuals can gain both mass and strength.  Available Sarcopenia Assessments: SARC-F  A simple questionnaire that is a good point of reference but an easy assessment if you're active.  How it works: Includes 5 components with scale scores range from 0 to 10: Strength: How much difficulty do you have in lifting and carrying 10 pounds? Assistance in walking: How much difficulty do you have walking across a room, whether you use aids or need help to do this? Rise from a chair: How much difficulty do you have transferring from a chair or bed, whether you use aids or need help to do this? Climb stairs: How much difficulty do you have climbing a flight of 10 stairs? Falls: How many times have you fallen in the past year? Flipping 50 Fitness Scorecard  Helps not only measure strength and muscle mass but to see how you rank according to others in your age group.  Most important is progress, comparing you to you. Start where you are by benchmarking it and learn how to improve it. How is Sarcopenia Diagnosed? Fat-Free Mass Index: FFMI ≤ 15 kg/m2 Visit this URL to calculate (turn on metric to see result): https://ffmicalculator.org/ A strength test. What is Sarcopenia: The New Glossary Osteosarcopenia - low bone mass and low muscle mass Sarcobesity - low muscle mass and high fat mass Osteosarcobesity - low bone mass, low muscle mass and high fat mass  Osteobesity - low bone mass and high fat mass    The biggest risk of sarcopenia is falling due to instability and inability to “right” yourself when slips and falls occur. I promised we'd visit what's possible so here that is: A 1.9-3.3% increase in global muscle mass in humans is associated with a 4.1% to 5.8% lower fat mass and reduced A1c and fasting glucose in studies lasting 2 weeks to 3 years.   How to Avoid Sarcopenia? Resistance train 2x per week minimum, for some that's maximum. Know your recovery needs. Consume high protein foods and micronutrient dense foods at each meal.   Wouldn't it be wonderful if in 30 or 40 years, “What is sarcopenia?” is a question like “What is scurvy or rickets?” now which is never heard of. That starts with us.    References:  Nutrients. 2023, PMID: 38201856. Sports Medicine, 2025, PMID: 40576707. Advances in Nutrition 2025, PMID: 40222723. Scientific Reports, 2025, PMID: 39833326. Front Med (Lausanne), 2025, PMID: 40636391.   Other Episodes You Might Like: Previous Episode - Stronger Muscles, Longer Life: The Untold Value of this Accessible to All Anatomy Next Episode - How Mold Toxicity Affects Hormonal Balance During Menopause And Effective Detox Strategies More Like This: 5 Reasons You're Not Losing Weight or Gaining Muscle After 50 Protein for Menopause Hormone Support Where Protein Recommendations for Women Come From?   Resources:  Don't know where to start? Book your Discovery Call with Debra. Use Flipping 50 Scorecard & Guide to measure what matters with easy at-home self-assessment test you can do in minutes. Opening in August!! Join the Hot, Not Bothered! Challenge to learn why timing matters and why what works for others is not working for you.  

If you're wondering how the heck my clients are eliminating overeating and judgmental thoughts, without going on another restrictive diet or giving up their 10pm ice cream…it's because they're rewiring all the sneaky ways diet culture still lives rent-free in their heads.   >> It's about learning how to respond when the old patterns come roaring back. >> It's about WHAT TO DO when it's 9pm and you're standing in front of the pantry with zero hunger    AND…   It's about rebuilding trust with your hunger cues, ditching the food guilt, and embracing a life where dessert isn't a bad word.    Which is precisely what I did with my client, whose relationship with food + her body (and her LIFE) changed massively in just under a year…all because she stuck with it when things felt hard.   Together, we worked through 4 key areas where she got stuck along the way:   1️⃣

What if everything you've been told about healthcare is backward? Dr. Leland Stillman joins Scott Ford to reveal how modern medicine has become an ascension marketing model – starting with inexpensive prescriptions before gradually escalating to costly procedures, all while failing to address the foundations of true health.For busy professionals and entrepreneurs, this broken system presents unique challenges. When you're juggling responsibilities and operating on tight schedules, you need healthcare that respects your time while addressing root causes, not just symptoms. Dr. Stillman shares his revolutionary approach to simplifying complex health information while maintaining a comprehensive perspective – what he calls focusing on the "low-hanging fruit" before pursuing specialized interventions.The conversation takes a fascinating turn when exploring the critical importance of light exposure. As humans evolved under natural sunlight, our bodies depend on specific light frequencies found in sunshine. Modern artificial lighting lacks the beneficial infrared spectrum present in natural light, correlating with increasing rates of chronic diseases. Contrary to popular belief, appropriate sun exposure actually associates with lower mortality rates across numerous studies.For those seeking optimal health, Dr. Stillman recommends three fundamental areas: working with a qualified provider who monitors key biomarkers (including hemoglobin A1C, ferritin, DHEA, CRP, vitamin D, and omega-3 levels), getting adequate natural light exposure, and ensuring proper darkness during sleep hours. These simple yet powerful approaches align with our biological rhythms and support cellular energy production, hormone regulation, and metabolic health.As Dr. Stillman powerfully states, "If you do not consciously make time for your wellness, you will be forced to make time for your illness." Ready to transform your approach to health? Visit stillmanmd.com to learn more about Dr. Stillman's practice or stillmanwellness.com to sign up for his newsletter and educational resources.Dr. Leland StillmanIntegrative and Functional Medicine PhysicianStillman Wellness405 Fifth Avenue South, Suite 200, Office #6Naples, FL 34102Hear Past episodes of the Way2Wealth Podcast!https://theway2wealth.com Learn more about our Host, Scott Ford, Managing Director, Partner & Wealth Advisorhttps://www.carsonwealth.com/team-members/scott-ford/ Investment advisory services offered through CWM LLC, an SEC-registered investment advisor. Carson Partners, a division of CWM LLC, is a nationwide partnership of advisors. The opinions voiced in the Way to Wealth with Scott Ford are for general information only and are not intended to provide specific advice or recommendations for an individual. Past performance is no guarantee of future results. All indices are unmanaged and may not be invested into directly. Investing involves risk, including possible loss of principal. No strategy assures success or protects against loss. To determine what may be appropriate for you, consult with your attorney, accountant, financial or tax advisor prior to investing. Guests on Way to Wealth are not affiliated with CWM, LLC. Legado Family is not affiliated with CWM LLC. Carson Wealth 19833 Leitersburg Pike, Suite 1, Hagerstown, Maryland, 21742.

Andy compares his anger and his A1C with others, Josh relives Live Aid, Andy defends religion against punks, Josh and Allison's anniversary, taking our summer break, listener questions, and much more Spiraling.

Send us a message (& include the best way to reach you)Blood sugar imbalances impact not just nutrition but high performance, affecting focus, mood, cravings, hormones, and resilience under pressure. We explore how glucose instability might be the hidden culprit behind your energy crashes, brain fog, and disrupted sleep patterns.• Blood sugar rises and crashes affect both body and brain, causing mental drain and mood swings• Waking between 1-3 AM often signals blood sugar dipping too low, triggering cortisol spikes• The Stress Mood Metabolism Lab offers insights through simple home testing of hemoglobin A1c, cortisol, thyroid function, and vitamin D• Continuous glucose monitors from Theia Health or Stelo help track personal responses to food, stress, and sleep• Every meal should include protein, fiber and healthy fat to slow digestion and stabilize blood sugar• Just 10 minutes of walking after meals can reduce glucose spikes by up to 30%• Morning sunlight combined with protein resets cortisol rhythm and stabilizes blood glucose• High-quality coffee can be beneficial when used wisely - timing and method matterBook your free consultation with me to determine which lab test might be best for you. Visit jeffreymort.com/resources for product recommendations and jeffreymort.com/learn for free high-performance health education.Support the showAs a token of gratitude, of course you're interested in these FREE and powerful resources, and because you enjoy the show, be sure to leave your 5-STAR Review HERE! >Join From The Heart: Your feel good feed packed with inspiring stories, wellness tips, and expert insights. Let's recharge your energy, balance your vibes, and celebrate YOU every Sunday morning. > You might be wondering just how full your Toxin-Tank may be: Take your FREE Toxicity Assessment to find out - no email required! > You'll discover a new level of self, after your FREE 2-Part audio training for Confidence! > Love to Read? You can lean more about Integrative Health on our Blog > I know you're concerned about your future. Schedule your FREE Consultation with Jeffrey

In this episode, I sit down with Christina O'Connor, RD, Senior Healthcare Account Manager at Pendulum Therapeutics, to explore one of the most fascinating—and overlooked—players in gut health: Akkermansia muciniphila. Christina shares how Pendulum became the first company in the U.S. to commercialize live Akkermansia, a keystone probiotic strain with far-reaching effects on blood sugar, weight, mood, inflammation, and energy. Topics we cover: ✅ How gut health is at the root of not just digestion, but metabolic health, immune resilience, mood, energy, and longevity. ✅ Why live Akkermansia muciniphila — a next-generation probiotic strain Pendulum pioneered — is transforming the way we approach gut and metabolic care. ✅ Why the question people should be asking isn't “What's the best probiotic?” — but rather “What probiotic supports metabolic health? Because that's the best probiotic.” (Hint: the answer is Pendulum.) ✅ How Pendulum is bridging ancient wisdom around gut health with cutting-edge science, backed by clinical studies and rigorous manufacturing. ✅ How caring for the gut can help people better navigate blood sugar balance, cravings, healthy weight, energy, digestion, sleep, and mood. Whether you're dealing with blood sugar imbalances, unexplained fatigue, emotional ups and downs, or weight plateaus, this episode will expand the way you think about gut health. ✨ Get a discount on your order by using code CLAUDIA at pendulumlife.com Follow the host, Claudia, on Instagram, check out HealingTheSource.co & Elham's Liquid Gold 100% Organic Castor Oil, and enjoy her deep-dives on Substack

In this week's episode, Lauren is joined by Debbie Lehr, a recent graduate of the DCB coaching program and a type 1 diabetic of 30 years. Though Debbie had always felt in control of her diabetes, a cross-country move and the onset of menopause left her feeling stuck, isolated, and overwhelmed- resulting in her highest A1C ever. After hearing about Risely through her daughter's best friend, Debbie took a leap and joined the program, seeking both support and a fresh start. What followed was a powerful transformation: within three months, Debbie lowered her A1C, stabilized her blood sugars, and found renewed confidence in her management. In this candid conversation, she shares how community, structure, and learning her own patterns helped her go from frustrated to empowered. This episode is a reminder that even after decades with T1D, it's never too late to ask for help and that real change begins with connection.Quick Takeaways:Knowing when it's time to ask for more help (and it's never too late) Overcoming fear and gaining confidence with your diabetes The powerful role mindset AND community plays in T1D management Timestamps:[04:03] The moment Debbie felt like she truly reclaimed her life with T1D [09:21] “I really felt defeated before I went to Risley”[13:17] Debbie's biggest wake up call: “I've learned my body and I thought I knew it before but I didn't.”[14:42] T1D + relationship to food [18:26] Navigating overwhelm and taking control [18:57] Finding AND understanding your patterns [21:39] The power of not having to struggle alone [24:58] Debbie's A1C journey & past endo experiences [31:00] Overcoming fear with T1D management (giving ‘too much' insulin / going low) [37:21] The importance of mindset and how to reframe it [37:47] What Debbie credits for her transformation[38:56] Dissecting the process of coaching [40:07] ‘80% mental and then 20% of doing all the steps'What to do now: Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.Apply for coaching and talk to our team so you can reclaim the life you deserve. Hear Debbie's story on IG: HERE!

Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. If you've ever felt powerless around food, it's not because you're lacking discipline. It's because your hunger hormones are in the driver's seat.Behind the scenes, hunger hormones like ghrelin, leptin, cortisol, and insulin are constantly working to regulate your appetite and energy. But when things like poor sleep, skipped meals, or a diet heavy in processed foods throw those hormones off balance, it can feel like your cravings are calling the shots.That's exactly why I created the FREE 3-Day Hunger Hormone Reset Mini Video Series—to help you stop blaming yourself and start working with your hormones instead of against them.This episode gives you a sneak peek into one key player: ghrelin, your body's internal food radar. We'll explore why it ramps up cravings, how to calm it, and how one simple breakfast swap helped one patient bring their pre-diabetic A1C back into a healthy range.ReferencesGet Your FREE 3-Day Hunger Hormone Reset Mini Video SeriesAudio Stamps01:32 - Dr. Rentea introduces her FREE 3-Day Hunger Hormone Reset Mini Video Series, which condenses a decade of experience into three short videos and PDF guide.04:10 - Today's episode focuses on the hunger hormone ghrelin, which drives hunger and heightens food awareness.05:33 - Discover three key factors which can increase ghrelin levels.07:42 - Learn why prioritizing protein at breakfast (and every meal) is crucial for managing hunger hormones.10:00 - The difference between eating at early hunger versus late hunger and why timing matters.11:23 - Additional strategies like food pairing and reducing ultra-processed foods to optimize ghrelin.Enrollment is now open for the September 30/30 program! JOIN NOW and get immediate access, live calls start in September. Premium Season 1 of The Obesity Guide: Behind the Curtain -Dive into real clinical scenarios, from my personal medication journey to tackling weight loss plateaus, understanding insulin resistance, and challenges with GLP-1s. Plus, get a 40+ page guide packed with protein charts, weight loss formulas, and more. Pre-register for the Sep 30/30 group.Support the show

On this episode of Crazy Wisdom, Stewart Alsop talks with Larry Diamond, co-founder of Healing with the Diamonds, about his journey from severe metabolic illness to vibrant health and his work helping others do the same. They explore topics like heart-brain coherence, the alchemical journey, insulin resistance, seed oils, and the deeper spiritual dimensions of healing, weaving in references to David Hawkins, Rupert Sheldrake, and the lost wisdom of the divine feminine. Larry shares insights on metabolic testing, ancestral eating, and the importance of authentic living, while also touching on the role of parasites—his term for the forces keeping humanity in fear and incoherence. You can find more about Larry and his work, as well as access his consulting, at healingwiththediamonds.com, on Instagram and Facebook at Healing with the Diamonds, or listen in iTunes to his upcoming podcast.Check out this GPT we trained on the conversationTimestamps00:00 Stewart Alsop introduces Larry Diamond of Healing with the Diamonds; they discuss his healing journey, health coaching, and the meaning of heart-brain coherence.05:00 Alchemical journey, crystals, the hero's journey, integrating masculine and feminine energies, and the idea of parasites feeding on fear.10:00 Kindness vs niceness, morphic fields, Rupert Sheldrake's theories, and quantum entanglement as evidence of interconnectedness.15:00 Scientism vs true science, metabolic illness, citizen science, Larry's 2013 health transformation.20:00 Metabolic syndrome, C-reactive protein, fasting insulin, insulin resistance, and Larry's weight loss story.25:00 Seed oils, refined carbs, ultra-processed foods, and strategies for restoring metabolic health.30:00 Carb cycling, primal eating, intuitive healing, and ancestral wisdom.35:00 Spirituality beyond religion, Yeshua vs Jesus, divine feminine, and writing your own gospel.40:00 Living authentically, kindness in daily life, and finding healing in sovereignty and connection.Key InsightsLarry Diamond shares how his journey from severe metabolic illness to vibrant health became the foundation for Healing with the Diamonds. He explains how hitting rock bottom in 2013 inspired him to reject mainstream dietary advice and embrace a primal, whole foods approach that reversed his insulin resistance and helped him lose over 100 pounds.A major theme of the conversation is heart-brain coherence, which Larry describes as essential for true wisdom and discernment. He connects this to ancient teachings, referencing Yeshua's “sword of discernment” and suggesting that Western culture intentionally suppressed this knowledge to keep people in fear and mental fragmentation.The episode explores the alchemical journey as a metaphor for inner transformation, likening it to Joseph Campbell's hero's journey. Larry emphasizes integrating masculine and feminine energies and overcoming ego as key steps in remembering our divine nature and embodying authenticity.Larry critiques scientism, which he calls the inversion of true science, and encourages listeners to reclaim citizen science as a path to health sovereignty. He shares practical tools like testing for C-reactive protein, A1C, fasting insulin, and using triglycerides-to-HDL ratios to assess metabolic health.He identifies the “Big Four” dietary culprits—seed oils, refined carbs, ultra-processed foods, and sugar—as drivers of chronic illness and advocates returning to ancestral foods rich in natural fats and nutrients. He stresses that flavor and enjoyment are critical for sustainable healing.On the spiritual side, Larry reframes the Abrahamic religions as distortions of deeper wisdom traditions, contrasting the figure of Yeshua (aligned with love and sovereignty) with the institutionalized Jesus narrative. He highlights the divine feminine, Sophia, as a source of intuition and co-creation with the cosmos.Finally, Larry encourages listeners to “write your own gospel and live your own myth,” seeing authentic, kind, and sovereign living as both a spiritual and practical act of resistance to what he calls the parasite class—forces of fear and manipulation seeking to block human awakening.

In this episode of the Diabetes Innovators Series, the conversation explores the evolution of diabetes treatment, the challenges faced in managing diabetes today, and the future of diabetes research. Zan, an endocrinologist and former FDA executive and Founder and executive chairman of Kinexum, shares insights from his career, including the historical context of diabetes management, the importance of A1C as a marker, and the potential of new treatments like GLP-1 agonists. The discussion also touches on the concept of meta-abesity, the shared root causes of chronic diseases, and the need for a focus on health span rather than just lifespan. Chapters 00:00 Introduction to Diabetes Innovation Series 03:06 Zan's Journey in Diabetes Research 06:05 Transforming Diabetes Treatment: A Historical Perspective 09:00 The Evolution of Diabetes Management Tools 11:42 Challenges in Diabetes Management Today 14:41 The Future of Diabetes Treatment: Aiming for a Cure 17:57 Understanding the Drug Approval Process 20:32 Meta-Abesity: A New Perspective on Chronic Diseases 23:48 Innovations in Longevity and Health Span 26:27 The Role of GLP-1 Agonists in Diabetes Management 29:29 Future Directions in Diabetes Research 32:29 Memorable Moments in Drug Proposals 35:37 Conclusion and Future Collaborations Resources: Kinexum Zan Fleming

Season 3 of the Long Blue Leadership podcast is a wrap! From established national leaders to rising stars, this season features inspiring stories from U.S. Air Force Academy graduates. SUMMARY This season's guests included Dr. Heather Wilson '82, former Secretary of the Air Force; Dr. John Torres '82, NBC News Senior Medical Correspondent; Maj. Gen. Thomas Sherman '95, Vice Superintendent of the U.S. Air Force Academy, and 2nd Lt.  Wyatt Hendrickson '24, NCAA wrestling champion.   SHARE THIS EPISODE LINKEDIN  |  FACEBOOK    TAKEAWAYS Leadership is about collecting tools over time. Your identity is not defined by your profession. Intentionality in actions leads to personal growth. Leadership can be practiced at any level. Admitting mistakes quickly is crucial for growth. Respect and loyalty are earned through care. Every moment is an opportunity to make an impact. Legacy is built in real-time interactions. Conversations can unlock deeper insights about leadership. Sharing stories fosters connection and learning.   CHAPTERS 00:00 Celebrating leadership lessons from Season 3 03:07 Insights from Dr. Heather Wilson '82 05:47 Chad Hennings '88 on identity and leadership 08:55 Young leader Wyatt Hendrickson's '24 journey 11:51 Jemal Singleton '99, leading where you are 14:53 Emma Przybyslawski '10 on leadership beyond the uniform 17:49 Dr. John Torres '82, earning respect and loyalty 20:37 Maj. Gen. Thomas P. Sherman '95 on trust, courage, and legacy 23:47 Looking ahead to Season 4   ABOUT OUR HOSTS BIO's LT. COL. (RET.) NAVIERE WALKEWICZ '99 Senior Vice President, Engagement With over two decades in leadership roles, my current focus at the Association of Graduates - U.S. Air Force Academy is fostering a robust network of 50,000+ alumni. This commitment involves igniting a culture of engagement and inclusivity, underpinned by a strong foundation in support of our Air Force Academy. - BIO COPY CREDIT:  LINKEDIN.COM MR. WYATT HORNSBY Senior Vice President, Marketing & Communications | Executive Producer Wyatt Hornsby is passionate about developing marketing and communications talent and cohesive, high-performance teams. He is senior vice president of marketing and communications at the Air Force Academy Foundation and the Association of Graduates. He leads the work of the foundation and alumni association marketing and communications division, while also coordinating with various Air Force Academy offices, including Public Affairs and Strategic Communications. - BIO COPY CREDIT:  LINKEDIN.COM     CONNECT WITH THE LONG BLUE LEADERSHIP PODCAST NETWORK TEAM Send your feedback or nominate a guest: socialmedia@usafa.org Ted Robertson | Producer and Editor:  Ted.Robertson@USAFA.org  Ryan Hall | Director:  Ryan.Hall@USAFA.org  Bryan Grossman | Copy Editor:  Bryan.Grossman@USAFA.org Wyatt Hornsby | Executive Producer:  Wyatt.Hornsby@USAFA.org      ALL PAST LBL EPISODES  |  ALL LBLPN PRODUCTIONS AVAILABLE ON ALL MAJOR PODCAST PLATFORMS     FULL TRANSCRIPT SPEAKERS Co-Hosts:  Lt. Col. (Ret.) Naviere Walkewicz '99  |  Mr. Wyatt Hornsby   Naviere Walkewicz  00:26 Welcome to our retrospective for Season 3. We're celebrating the first three seasons of the Association & Foundation's premier podcast and the countless leadership lessons shared by some of the most accomplished Air Force Academy grads.   Wyatt Hornsby  00:41 Naviere, in Season 3, we've showcased some amazing stories and takeaways that apply to life, both in and out of the military. From the start, Long Blue Leadership has given listeners an inside look at real experiences, insights and advice from seasoned leaders as well as those just beginning their journeys. These deep dives explore how leaders not only face challenges head on, but also find ways to inspire and empower those around them.   Naviere Walkewicz  01:06 These conversations are amazing. What really sets this podcast apart are how these leadership discussions consistently touch on teamwork, perseverance, humility, excellence and service before self.   Wyatt Hornsby  01:17 Well said, Naviere. And in this edition of Long Blue Leadership, we're gonna respond to a few clips and share our own perspectives related to some of our favorite moments, and we'll also preview what's coming up in Season 4.   Naviere Walkewicz  01:30 Now Wyatt and I would be remiss if we didn't share — listen, we could go on about every guest that's on this podcast, because everyone is remarkable, but we're just going to focus on a few of them. So let's jump right into some of our favorite moments from Season 3.   Wyatt Hornsby  Let's do it.   Naviere Walkewicz  All right. Well, this first clip is someone that you're going to recognize: Dr. Heather Wilson, Class of '82. What an amazing graduate. And you know, when we think about what she's accomplished — she's a Distinguished Graduate, secretary of the Air Force, I mean, going on into Congress — she is a mentor for many. And this particular clip, she actually is referring to someone who's been a mentor for her and being able to make an impact in his life. So let's take a listen.   Dr. Heather Wilson  02:12 My grandfather was an aviator. He was also a mechanic. He could use any tool. I mean, he was just amazing with his hands. And I had learned a new tool in school, and I took out a piece of graph paper, and I drew a curve, and I said, “Grandpa, do you think you could find the area under this curve?” And he said, “Well, I'd probably count up the squares and estimate from there on the graph paper.” And I then I showed him something new, and it was called calculus, and it was the first time in my life that I realized I had a tool that my grandfather didn't have. He had a high school education and had gone into the RAF during the First World War, and he was a great mechanic and a really good man, but I realized that there were opportunities for me that maybe my grandfather never had.   Naviere Walkewicz  03:14 What an amazing conversation with her. What did you think about that comment about the tool?   Wyatt Hornsby  03:19 That's very, very moving. You can see just what her grandfather, what he meant to her, and just to think about those experiences and how they informed and influenced how Dr. Wilson has been a leader to so many in Congress, as secretary of the Air Force and now as president of the University of Texas, El Paso.   Naviere Walkewicz  03:38 Yes. And when you go back to that conversation, I think she talks about tools in a toolbox, and she relates it to her grandfather and her dad, I think, as well. But she talks about the toolbox almost serving as — you never know when you're going to need a tool. So as long as you collect tools over time, they can make a difference. And so she likens them to the people in your life and the people who serve with you and under you and above you. But if you start to recognize the tools that they have, you never know when they're going to make a difference. And in her case, she was actually able to provide a tool like calculus for her grandfather.   Wyatt Hornsby  A great lesson.   Naviere Walkewicz  Yes, yes. So make sure you take a listen on that one.   Wyatt Hornsby  04:15 Well, Naviere, this next conversation I absolutely love — Chad Hennings, Class of 1988, who went on, I believe, to serve in the Gulf War, flew the A-10 before joining the Super Bowl-winning Dallas Cowboys. And I love this conversation. Chad talks in this conversation about who you are isn't necessarily what you do. It comes from who you are from within. I just love this clip. Let's listen to it.   Chad Hennings  04:41 One of the questions that I ask someone who is changing and transitioning in their careers, whether that be from professional athletics or from the military, I ask them, “Who are you?” You know, a lot of times they'll say, “I'm well, I'm Captain so-and-so,” or, “I'm a former F-16 fighter pilot,” or, “I'm a former running back.” I go, “That's what you do. Who are you? What you do does not define who you are.” I mean, that's the thing that I think so many people need to grasp, is that their identity is not based on what they do. It's more of an inner pursuit.   Naviere Walkewicz  05:14 Well, I won't put you on the spotlight and ask you who you are, but I remember that conversation, and it was really quite a reflective one for me, because I remember, as he was sharing those things, I started thinking, “Well, who am I, you know, as a leader, etc.” So that was really meaningful.   Wyatt Hornsby  05:30 Indeed. I mean, all across our lives and careers, we do a lot of different things. We wear a lot of different hats at various points, and I think it's hard, but I think it's so meaningful to really reflect on your own personal values in determining really who you are from within. I just loved how Chad talked about that.   Naviere Walkewicz  05:50 Yes, that was just one of the lessons that he shared. And I think it really kind of goes back to understanding yourself and growing as a leader. So it's certainly a wonderful conversation for those interested. Well, let's take a visit to one of our younger graduates. Most recently, 2024 class, and his name is Wyatt Hendrickson, so another Wyatt here. Some might remember him as Captain America. I think he's been called that lately, in the news, but known for just his accomplishments in the world of wrestling and what he's continuing to go on, hopefully here in the Olympics. But this conversation really is about some real insightful moments that I think he's had as a young leader, that he recognizes the importance of doing things for yourself. And some might first think, “Well, that sounds kind of selfish, right? You know, we're taught to be team members and team players and do things together.” But when we, when we listen to this clip, I think we understand why he talks about doing things for yourself. Let's take a listen.   Wyatt Hendrickson  06:49 As a leader in at the Air Force Academy, I started going to these briefs, and I'm like, “You know, I'm not going to try to have the a bad mindset. I'm not going to show up here, just check a box. I'm going to show up here and try to take something from it.” So what I did, I bring like a notebook or a small little pamphlet, just to write notes. And everything you do, do it with intent. Don't do it because you're afraid of a bad result — you're afraid of something here, there. Do it because you want to do it, and you have to decide you're doing it for yourself.   Naviere Walkewicz  07:18 You know, what I really like about that clip is understanding that you have to do things for yourself and not others. And so I liken it — you know, we are parents, and at one time we are children. And so we probably did things. We do things as parents for your children. When you're a child, you do things because you don't want to make your parents unhappy, or you want to make your teacher proud or your coach proud. And I think he learned early as a leader that if you're going to do something with intent, to do it for yourself. What do you think?   Wyatt Hornsby  07:44 That's right. Being able to invest in yourself so that you can show up for others as well. And so I think when you really consider that, he's really talking about a little bit of service before self within that as well. And I think it's working out well for him. You know, he just pulled off, some say, the biggest upset in NCAA wrestling history. And I agree, we'll hope that he gets to the Olympics. Just what a remarkable young leader and athlete.   Naviere Walkewicz  08:11 Yes, and what an exciting and engaging conversation that I hope you'll take a listen to as well. There were some exciting moments in there that he experienced, I think. You know, with the president and, you know, just kind of reflective moments with his coach, but certainly a conversation that many will be engaged by.   Wyatt Hornsby  08:28 And when we talked to him, his life was very busy, and we just so appreciate him taking time to talk with you, Naviere.   Naviere Walkewicz  Yes, absolutely.   Wyatt Hornsby  All right. Naviere, this next guest I absolutely love — Jemal Singleton, Class of 1999.   Naviere Walkewicz  Gold will shine.   Wyatt Hornsby  That's right, assistant head coach for the Philadelphia Eagles, also coach for running backs for the Eagles. And this was such a great conversation. We were you were able to go to Philadelphia and sit down with Jemal and really hear his story and something — I mean, the conversation was just full of great insights. But one thing that Jemal said that I absolutely loved was, no matter where you are in your life and career, lead where you are. You don't have to have a big team or direct reports, just lead where you are. So let's listen to that clip.   Jemal Singleton  09:17 I think the biggest thing that you can do is lead where you're at, and it doesn't matter where you're at. “Oh, well, I'm not the CEO,” or, “Oh, I'm not the head coach,” or, “Oh, I'm not the commander.” So? Leadership comes in a million different ways. And I truly believe that you know kind of what you do with the little things, is how you do everything. And if, in your position, whatever it may be — maybe nobody even works for you — you can still lead from that position. You can lead from that spot. And I think that's it. Don't be afraid to step out. Don't be afraid to be a leader in your own mind. It's got to start there. At some point, you keep honing those skills and then maybe you are going to grow. And then, hey, you have three people working for you, but you then be a leader at that point. And it's kind of like what I mentioned earlier, about be where your feet are; lead where your feet are at.   Wyatt Hornsby  10:09 What a great insight. And I think that is just so helpful for not only people who are earlier in their career, and maybe they want to be able to grow as a leader. But also for leaders as well, in terms of how they instill in the people who they're privileged to lead, how they can continue to grow and advance.   Naviere Walkewicz  10:30 Yes, what a great life lesson in general. I think sometimes we are so eyes forward on the next thing, that we forget to be our best at the present and the moment. And that was a really, I think, a key message that I took from that was, you know, when he says, lead where you are, you know, be fully present where you are, just like we are right now, reliving, kind of that moment with him. And so what an engaging and amazing conversation with Coach Jemal Singleton. Of course, being a '99 grad, you'd expect that, but, you know?   Wyatt Hornsby  10:58 We wish him. We wish him all the best. What a run he's on right now. Congrats to the Eagles.   Naviere Walkewicz  11:03 Yes. And if I may just offer this: I did want to extend to the team with the Eagles — I mean, what a world class operation out there, to be able to invite us in and put us in their amazing studio to help us share the story that really goes beyond the football, right? It goes beyond the field and how they're doing things as leaders out there. So thank you so much for that amazing support. We really appreciate it. All right. This next clip, Wyatt, is someone that we know well. She is one of our past AOG board directors, Class of 2010, Emma Przybyslawski, also a Young Alumni Excellence Award winner for us, what a remarkable leader. You know, she served in the Air Force, in the special operations community, but also went on after the uniform to really kind of lead her team and her business. In this particular clip, she's talking about leadership outside of uniform. And I think it's important for our listeners to know that leadership comes in and outside of uniform, and so we want to make sure we highlight that. But this particular clip, she talks about getting to “no” as fast as you can — and that's an odd statement to hear, but I think it's really impactful.   Emma Przybyslawski  12:14 One of my key tenets is having the stomach to say, like, “Oof, this didn't work out the way that I wanted it to,” or, “Maybe we were wrong about that.” Step 1, right? Admitting the problem. Step 2 is then pivot, move on, let it go. Just let it go, and either take some great lessons learned from it — hopefully you do — or just bail on it and like, go on to something different. Get to no as fast as you can. Like, no is an OK answer, but man, let's get there as fast as we can. Because the more time you iterate and waste on bad ideas that you don't know if they're bad yet, that they're going to be, the sooner you can get to no, the better off you are.   Naviere Walkewicz  12:59 I really like that, just because it's so different. I mean, it's a different perspective on being thoughtful. on resources and time and how you actually utilize all that as a leader and when you're making decisions that impact others. I just thought that was really insightful. What'd you get from it?   Wyatt Hornsby  13:16 I agree, and what I hear from that is integrity and discipline. No one likes to admit that they're wrong. It's not the most fun thing in the world, but what I heard Emma say was, “If we got something wrong, just admit it. Get there as quickly as possible, learn and move on.” So I love that leadership insight.   Naviere Walkewicz  13:33 Yes, and when you look through history and you think about, those greats, those innovators — but you know, over time, they failed because they failed to actually move forward or stop something that was no longer working. They just held on so tight. I think as a leader, it's important to recognize that. And her, as you know, such, I think, a young and enthusiastic and, you know, impactful leader realizing that it's an important lesson I think we can all take.   Wyatt Hornsby  13:56 It's easy to see, you know, when we hear Emma talk about leadership, it's easy to see how far she's come in life, and, you know, what she's been able to do.   Naviere Walkewicz  14:05 Yes, so make sure you listen to that. While she does talk about that outside of uniform, she does share some incredible stories while she was in the special operations community. I think our listeners will really enjoy learning some of that too.   Wyatt Hornsby  14:16 All right, Naviere, our next guest, Dr. John Torres, Class of 1982 — and that's a name that many of our listeners and viewers may be familiar with. Chief medical correspondent for NBC News. And I love this conversation. Dr. Torres was able to take time from his schedule and visit with us here in Wecker Hall. And really what he talked about, what I took away from this was that leaders earn respect and loyalty. They take care of their people, and they put their people really before themselves. So let's listen to this clip.   Dr. John Torres  14:47 Watching leaders and how they did things, both when I was here at the Academy and when I was in the Air Force and even through medical school, the doctors that were good and talked to people appropriately. The leaders that were good and they had the men and women following them because they wanted to follow them, versus following them because they had to follow them. And as you know, there's a huge difference there. And I tried to model myself after the ones who had people who followed them because they wanted to follow — they respected them. They earned that respect. They earned that loyalty. And to me, that was always an important thing. And so when I transitioned over to medicine, especially being a flight doc, I wanted them to do the things that medically were important for them because they wanted to, because they trusted me, and they understood that I was looking out for them and not just their career or not just their flying, but looking out for them and their families.   Naviere Walkewicz  15:32 I remember that conversation.   Wyatt Hornsby  15:35 Caring deeply about the person, and not necessarily what they — putting that before what they do.   Naviere Walkewicz  15:41 Exactly. That conversation went on because it was referencing the fact that, as a medical doctor in the service, you know, you had those that really wanted to fly like that was their calling. And when they had a medical issue arise, you know, Dr. Torres, because he led in the way that he did. He created that relationship and that trust, to be able to say, “This is what we're up against,” and, you know, to be able to make a leadership and a professional recommendation, and then that, you know, “I care about you as a person, so I'm gonna ask you to consider this,” even if it might be the hard decision that they'd have to make. And I think that that goes a long way for leaders, because sometimes we have to give bad news to our people.   Wyatt Hornsby  16:21 That's right, and really caring about those who were charged with leading and taking care of their best interests, sometimes having those tough conversations. But when we do that, when we authentically care about our people, they will respect us. They will trust and that's really what he was talking about. Powerful.   Naviere Walkewicz  16:43 I think we could probably both think about examples of leaders in our lives that maybe we didn't get the best news, but we always knew they had our best interests, and we would walk through fire for them.   Wyatt Hornsby  That's right.   Naviere Walkewicz  Yes, what a great conversation with an amazing speaker. You'll have to take a listen to the entire conversation with Dr. Torres, because his was really incredible. And the fact that he actually almost left the Academy, but stayed because of survival training. So you make sure you listen to that. All right. Well, this last clip we're going to visit is, gosh, I still just got goose bumps thinking about the conversation with him. It's a recent conversation with Maj. Gen. Tom P. Sherman, Class of 1995, the current vice superintendent of the Air Force Academy. And I could go on and on about, you know, the way he inspires through his words, but this particular clip, Wyatt, was one where he talks about courage, right? And when he recognized a moment in time. This is from a conversation with his AOC, back when he was a cadet at the Air Force Academy, and he had a moment of clarity.   Wyatt Hornsby  17:45 We've both had the opportunity to see Gen. Sherman speak, and just an incredible speaker and presenter — really gets to know his audience. So let's listen.   Maj. Gen. Thomas P. Sherman  17:57 But I think really where the Foundation came in is where we started to talk about leadership. And you know, what I was asking him to do was to pull my rated recommendation form. So we had just submitted them, and I was asking him to pull my rated recommendation form. I didn't want to compete for it anymore. And so we started to talk about leadership. And he says, “You know, hey, Cadet Sherman, you need to understand that, you know, leadership in this Air Force is being the lead F-16 pilot on a bombing run. You know, putting iron on target.” And that's true. It's a very important part of leadership. It is a very important part of tactical operational leadership in this Air Force. So he's not wrong in that space, but I was looking at it from a different lens, and I was looking at it, I think, on a larger level. And what I don't think he realized is that 30 seconds before I walked into his office, he set me up for success. I just happened to be waiting outside the office, and all of a sudden I looked on his cork board, and somebody, and I don't know who it was, had pinned a note that was written to Airman Magazine by an airman first class. And this airman first class titled this, “I need a leader.” And this A1C felt so strongly about what they were feeling, and I have no idea who this person was, felt so strongly about it that they put pen to paper — and this would have been the fall of 1994 — and sent this into Airman Magazine, and it says, “I need a leader. Commissioning sources: Send us lieutenants that we can look up to that will hold us accountable when we do wrong, that will encourage us when we do well, that will be an example that we can look up to, that will care about us as human beings, because you are not sending them to us now. Air Force: I need a leader.” Like that 30 seconds just before I walked into his office, that changed my life. And it changed my life, because for me, at that moment, what I was getting ready to go ask my AOC to do what I was looking at inside myself like that became my charge.   Wyatt Hornsby  19:57 Naviere, I mean, as a graduate, how does that land with you?   Naviere Walkewicz  20:01 I have chill bumps right now, and it's not because it's cold in here, because it's not. I think you nailed it when you said he's someone who can really kind of inspire through his words. But you know, when I hear him say that, it makes me want to go back through the Academy all over again. I want to do it again to see if I can do it better. Because I want to be a leader for that airman and for anyone else that is serving alongside me, under me, etc. That's what I felt hearing that again.   Wyatt Hornsby  20:33 Yeah, and just from the whole conversation, I mean, that's really, I think that's the essence of Gen. Sherman's career, in my eyes, is that he has done everything he can to deliver or to develop as a leader and to be able to bring out the best in everyone who he has had the opportunity to lead and work with.   Naviere Walkewicz  20:51 One of my favorite moments in that conversation was about, you know, “What do you want your legacy to be?” You know, I think that was some kind of — that was maybe a way that I asked the question, and his answer was so unique, because he said, “You know, I don't really think about legacy, like, down the road.” He says — it's almost like he thinks about it in real time, and I'm paraphrasing, so you'll have to listen to the conversation. But he talked about, like, his legacy is when he makes an impact in every moment. So, like, this, you and I together, if I'm able to make an impact through our conversation, like, that's his legacy. And in off the screen, I didn't get to share this in our conversation, but my son, Arden, he's a cadet now, and when I told him I was going to be doing this podcast with Gen. Sherman, he had nothing but amazing — “Mom, I would walk through fire for him. He's so amazing. He's so inspiring.” And I shared that with Gen. Sherman, I said, “Well, you should know, sir, that you created a legacy with my son,” and it actually brought some emotion to him, and that that's who he is. I think that's who we want to be.   Wyatt Hornsby  21:52 Absolutely a remarkable leader and just an amazing episode. And hope that you all take the time to listen to it.   Naviere Walkewicz  22:00 Yes. So those were our highlights from Season 3. And like I said, we could go on about every one of our guests, because they're so impactful and amazing. And just — we take something from each of them.   Wyatt Hornsby  22:12 We did Naviere, and I want to just take a moment too, just to thank you for doing such a great job in Season 3. And just not asking questions, but just having conversations. And it's just easy to see that this just is kind of like a conversation over coffee, where you're just talking about leadership and really getting a sense of what their journey has been, whether it's been the good or the not so good, but just really finding out who they are authentically. So thank you, Naviere, just for leading those conversations.   Naviere Walkewicz  22:43 It's my great pleasure. I think some of the best work behind the scenes comes from this place of wanting to help share their story in a way that our listeners may not have ever heard before, and almost unlocking within them something that surprises themselves, about themselves, you know what I mean? Where they're actually like, “Wow, I'm sharing this,” and it's almost unlocking this new portal on leadership, on themselves. And so that's kind of how I always approach preparation for a conversation. And my goal is just to leave someone with something that really resonates with them.   Wyatt Hornsby  23:18 Well done, Naviere. And while we're at it, we're going to put Ted, our producer, our amazing producer, on the spot here. Ted, congratulations again on a great Season 3. And what are you — just any reflections that you want to share?   Ted Robertson  23:33 Loving watching Naviere grow and glow as a host — she's just my favorite person ever to work with, and thank all of you. This doesn't happen without a whole team committing time and resources and effort, eyes, ears, ideas. It doesn't happen without this group effort. It's a wonderful, wonderful place to be in. Speaking of places to be, you're going to talk about this a little later. Some listener feedback coming up next that Wyatt is going to tell you about. But we have the gift of a new studio that you're some of you are seeing for the first time inside of our new building that we can't wait for many of you to see. So thank you both for everything you do, your support, your encouragement and giving me this couple of minutes to share my thoughts with all of you.   Naviere Walkewicz  Thanks, Ted.   Wyatt Hornsby  24:23 Yeah. Thank you, Ted, again, great work, and we're just we're very grateful for all the heart and soul you put into Long Blue Leadership.   Naviere Walkewicz  24:31 Well, up next, Wyatt has some listener feedback to share with you, but before we do that, I'd like to take a moment and thank you for listening to Long Blue Leadership. This podcast publishes the first and third Tuesdays of the month in both audio and video, and is available on all your favorite podcast apps. Be sure to watch or listen to all episodes of Long Blue Leadership at longblueleadership.org. Once more, that's longblueleadership.org   Wyatt Hornsby  24:58 And a note I saw from Allison D. in reference to Naviere's conversation, particularly with Emma Przybyslawski. And this highlights how hard Naviere has worked and how well she has done as host of Long Blue Leadership. And I'll start with Allison's note to Naviere, and then I'd like to add some thoughts of my own. From Allison: “Just wanted to do a quick shout out to let you know that I've been listening to your interview with Emma P. and I thought you did a phenomenal job. Emma's willingness to share her perspective in experiences in such an authentic way was a testament to her. But I also wanted you to know that while I was actively listening to her responses, I was also blown away by your ability to follow up with each response with an insightful and natural follow up question. My brain was still digesting her last response, and I don't know how you were able to digest and formulate such an interesting follow up question in such a short amount of time. Well done, Naviere.”   Naviere Walkewicz  25:58 I remember that comment. What a special moment to get that from Allison. Thanks for sharing that, Wyatt.   Wyatt Hornsby  26:05 Our pleasure, and thank you again, Naviere, for doing such a great job as our host.   Naviere Walkewicz  26:10 Well, Wyatt, let's talk about Season 4. It's coming out. Yes, some new things. Do you want to talk about kind of where we're in right now? What to expect?   Wyatt Hornsby  26:17 We're going to be having 13 episodes. Ten are going to be Long Blue Leadership, and then two are going to be really developmental focus, special presentations. Can't wait for that. And then, of course, we'll wrap up Season 4 with a retrospective, Naviere.   Naviere Walkewicz  26:31 Oh gosh, it's going to be amazing. I think what we've learned from the past seasons are people really enjoy hearing the stories from graduates that they can connect with — some transformational moments in their lives. But really excited. We kicked it off here at the end of Season 3 will be coming from our new studio here in Wecker Hall, so they'll get to see the studio and really hear the stories from our graduates. Those are really influential and key leaders in their fields.   Wyatt Hornsby  26:56 I can't wait. And some of our guests — they'll include academics, warfighters, general officers, business leaders, scholars, diplomats, entrepreneurs, policymakers and others.   Naviere Walkewicz  27:08 Yes, and you mentioned it, that kind of leadership. Those two special episodes on leadership, this focus on leadership, we're actually going to go to experts in a field. Maybe they're published authors, but they are going to be some real experts that help our graduates and our listeners hone in on their leadership development. So it's really going to give them some tactical and tangible things that they can do to improve on their own leadership.   Wyatt Hornsby  27:30 I can't wait Naviere, an exciting new feature on leadership as we just continue to elevate our game. It's going to be really great.   Naviere Walkewicz  27:37 It's going to be great. It's going to — that focus on leadership will kick off in October with our second one in December. Wyatt and I want to thank you for joining us today. We can't wait to share the fourth season of Long Blue Leadership with you. Starting this September, you can expect more compelling stories from outstanding Air Force Academy graduates. We like to keep the podcast conversations thoughtful and aimed at telling our guests stories as we explore their personal leadership journeys, their philosophies and their styles. Season 4 promises to engage, inspire and empower. Whether you're an aspiring, emerging or seasoned leader, visit longblueleadership.org for more episodes and past seasons, or nominate a guest or send us your feedback at socialmedia@usafa.org. Long Blue Leadership is available on all your favorites podcast apps.   Wyatt Hornsby  28:30 And Naviere, this was such a great conversation, and I want to encourage you, if you've listened to these episodes or you've watched and you were particularly inspired, please share across your social media channels, share with your friends and colleagues and family members, because we really want these conversations to be for anyone who's interested in developing as a leader, regardless of what career pursuit they've taken.   Naviere Walkewicz  28:54 We like to say “like, subscribe and share.” There you go. Well, I'm Naviere Walkewicz.   Wyatt Hornsby  And I'm Wyatt Hornsby.   Naviere Walkewicz  Until next time.   KEYWORDS Leadership, Air Force Academy, mentorship, personal growth, teamwork, perseverance, service, identity, respect, legacy.       The Long Blue Line Podcast Network is presented by the U.S. Air Force Academy Association & Foundation    

Dr. Nicole Rivera breaks down the real root causes behind the diabetes epidemic and why simply “managing numbers” isn't enough. She exposes the hidden dangers of processed foods, the limitations of conventional bloodwork, and shares what it actually takes to heal pancreatic function and reclaim your energy, mind, and long-term health. This is a wake-up call for visionary families and leaders who want to create generational health—by getting proactive, not just reactive.   #DiabetesPrevention #PancreaticHealth #IntegrativeMedicine #GenerationalHealth #RootCauseHealing #BloodSugarBalance #FunctionalMedicine #WellnessLeadership #RealFoodRevolution #LiveLimitless   3 Key Takeaways:   Most “normal” bloodwork is missing the full picture.Glucose and even A1C aren't enough—you need a comprehensive look at insulin, amylase, and lipase to truly assess pancreatic health and diabetes risk. Processed foods and chemical additives are sabotaging your pancreas. It's not just about sugar; it's about the hidden chemicals in your everyday foods that disrupt your body's natural ability to regulate blood sugar. You can heal and even reverse blood sugar issues—if you address the root cause. Sustainable results come from real food, lifestyle shifts, and understanding your unique biology—not just popping a pill or chasing “magic” solutions.  Quotes:  “Don't be the person that sits around saying, ‘My glucose has been great,' but you feel like shit. If you relate to the energy crashes, the cravings, the brain fog—there's an opportunity to actually do something about it.” “Are we just manipulating numbers so you feel better about the situation, or are we more interested in solving the root cause and expressing true health so that we don't have to fear disease and dysfunction?”   Find Integrative You Radio On: Website Youtube  Apple Spotify   2 Doctors Committed to Innovating the Healthcare Experience. Integrative You Radio is hosted by husband-and-wife duo, Dr. Nicole Rivera and Dr. Nick Carruthers. With their voracious curiosity for Integrative Medicine, the Human Mind, Aligned Parenting, and Entrepreneurship, they bring a fresh perspective to the table. They aim to debunk the BS that is holding you back in your health, your relationships, and your life. Each episode is designed to challenge your thinking, push boundaries, and inspire you to see your life through a new lens. Dr. Nicole and Dr. Nick share transformative insights that have revolutionized their lives and the lives of their clients at Integrative You. This is raw. This is real. This is Integrative You Radio— where we blow shit up for the sake of human innovation.   Links: Website: Integrative You Instagram: Dr. Nicole Rivera & Integrative You Book a Consult [yes, it's free] with our Concierge Coordinator & Dr. Nicole  We are fanatical about relationships. Working on your health, your mind, and essentially your life is the best thing you can do for yourself [and the people you love]. This is why we want to get to know you and make sure we are aligned so we can build a relationship rooted in trust and partnership for growth. If anything, you can at least use this call for clarity on your best move even if that is not working with us. We are here to provide value in this world, so just book the call: https://www.integrativeyou.health/onboarding Got questions? You can call or text us at 732-810-1084.

This episode reveals how fasting is the most powerful tool for preventing cardiovascular disease and reversing metabolic dysfunction that affects 88% of Americans. Dr. Scott and Tommy explain why fasting goes far beyond weight loss to address the root cause of heart disease: insulin resistance and dangerous blood sugar variability. Discover how consistent fasting protocols can dramatically reduce your risk when every 1% increase in A1C levels raises heart problems by 12%, major cardiovascular events by 8%, and heart-related kidney issues by 17%. Learn why diabetics with the highest blood sugar swings face 2.5 times higher heart disease risk - and how fasting flattens these dangerous glucose spikes. The hosts break down how fasting reverses metabolic syndrome (affecting 25% of the population) and helps the 70-80 million undiagnosed pre-diabetics who have normal A1C but dangerously high fasting insulin levels. Understand how fasting prevents the "rust on a bumper" effect of cardiovascular disease that develops slowly over decades. Get specific fasting strategies for reducing glycemic variability, controlling insulin spikes, and using intermittent fasting as cardiovascular protection. This episode reveals why monitoring fasting insulin during your fasting journey is more important than cholesterol panels, and how consistent fasting protocols reverse the inflammatory cascade leading to heart disease, stroke, and metabolic syndrome. Essential for anyone using fasting to prevent cardiovascular disease and optimize metabolic health for life. ⁠⁠⁠Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting!⁠⁠⁠⁠ Resources and Downloads: ⁠⁠⁠⁠SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL⁠⁠⁠⁠ ⁠⁠⁠⁠GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! ⁠⁠ ⁠⁠⁠⁠FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS!⁠⁠⁠⁠ ⁠⁠⁠⁠SLEEP GUIDE DIRECT DOWNLOAD⁠⁠⁠⁠ ⁠⁠⁠⁠DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE!⁠⁠⁠⁠ Partner Links: Get your⁠⁠⁠⁠ FREE BOX OF LMNT⁠⁠⁠⁠ hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase⁠⁠⁠⁠ here!⁠⁠⁠⁠ Get ⁠⁠⁠⁠30% off a Keto-Mojo⁠⁠⁠⁠ blood glucose and ketone monitor (discount shown at checkout)! ⁠⁠⁠⁠Click here!⁠⁠⁠⁠ Our Community: Let's continue the conversation. Click the link below to JOIN the ⁠⁠⁠⁠Fasting For Life Community⁠⁠⁠⁠, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them!

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Yvonne: Have just been advised, based upon blood work, that I have reduced pancreatic function (52.2%). My diet contains no sugar (I use stevia or monk fruit or natural sugars in fruits such as dates) and don't eat any highly processed foods, no gluten… so basically a clean diet. I also exercise, am not overweight. Was told I am pre-diabetic with an A1C of 6. Had a sample of a 4continuous glucose monitor - lowest rate was 5 and highest one time 2 hrs after eating was 10. I intermittent fast usually from about 2 - 3 p.m. until around 7 a.m. Is there anything else I can do to ensure pancreatic function doesn't continue to decline as I don't want to be on a pharmaceutical. Thanks.                                                            Lynn: I only recently heard about liposomal vitamins for the first time. Now I seem to be hearing about them everywhere, including on last week's House Call where you recommended Liposomal Glutathione to help with exposure to harsh toxins. Are liposomal vitamins better than "regular" vitamins. Or are there certain vitamins that are better if taken in liposomal form? Thanks!                                                                         Jenna: I had 6 meniscus, 1 PCL & 2 ACL surgeries. Thank you collegiate soccer. I noticed in my mid 20's after half of the surgeries, I would get a deep tingling and itch in my thighs while taking walks. I could prevent it from getting out of control if I had very tight compression workout pants on. But if I wore shorts, game over… I would scratch my thighs til it broke blood vessels. I don't know if it's a neurological or lymph/blood issue but no one seems to understand what I'm talking about. I would love to find an answer. I listened to the podcast about tingling skin but I'm not sure where to start.                    Anonymous: Hi Dr Cabral, thank you for all you do! Was just wondering how often and how much Moringa powder is safe to use? Would it be okay to add to a smoothie daily along with the greens powder and DNS? I have a Moringa tree and like to make my own powder. Also what are your thoughts on creatine for after or before a workout? Thank you             Laura: Hi dr. Cabral! Thank you so much for sharing all your experience and knowledge with the community! I have dealt with got issues probably my whole life and I've been told I probably have sibo and Candida. So I am currently doing the CBO protocol. At the end of my protocol, my family has a trip planned to go to Tokyo Japan. Do you have any tips for me of what I can do to not ruin all my progress? And keep my gut bacteria healthy? Should I start the CBO finisher while I am there? I also am interested in doing the parasite cleanse. Can I do the para cleanse while I'm doing the CBO finisher after I get home? Any travel suggestions would be great! Thank you so much!                                                                                                                       TAKEAWAYS     Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3431 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

In this episode of Intermittent Fasting Stories, Gin talks to Judy Cronander from Macomb, MI.Gin has a new YouTube Channel! Visit https://www.youtube.com/channel/UC_frGNiTEoJ88rZOwvuG2CA and subscribe today so you never miss an intermittent fasting tip, a community coaching session, or an interview with a past IF Stories guest or expert.Are you ready to take your intermittent fasting lifestyle to the next level? There's nothing better than community to help with that. In the Delay, Don't Deny community we all embrace the clean fast, and there's just the right support for you as you live your intermittent fasting lifestyle. You can connect directly with Gin in the Ask Gin group, and she will answer all of your questions personally. If you're new to intermittent fasting or recommitting to the IF lifestyle, join the 28-Day FAST Start group. After your fast start, join us for support in The 1st Year group. Need tips for long term maintenance? We have a place for that! There are many more useful spaces beyond these, and you can interact in as many as you like. Visit ginstephens.com/community to join us. An annual membership costs just over a dollar a week when you do the math. If you aren't ready to fully commit for a year, join for a month and you can cancel at any time. If you know you'll want to stay forever, we also have a lifetime membership option available. IF is free. You don't need to join our community to fast. But if you're looking for support from a community of like-minded IFers, we are here for you at ginstephens.com/community. Judy is retired, and she ran accounting departments for most of her career. Judy shares how a health scare in August of 2020 led her to discover intermittent fasting. After a hospitalization, Judy realized that many of her health issues were linked to her weight, prompting her to start intermittent fasting as a lifestyle change rather than just another diet. Initially skeptical about another dieting attempt, she soon found herself embracing intermittent fasting as a lifestyle.Judy's journey with intermittent fasting began with rapid success—she lost 39 pounds in just four months, ultimately shedding 90 pounds in her first year. Her second year of fasting involved significant body recomposition, with her size changes indicating fat loss even when the scale didn't go down. Judy details her struggles with various diets over the years, including Weight Watchers, where she initially found success but eventually regained the weight. This time, intermittent fasting offered a sustainable solution.Throughout her fasting journey, Judy has experienced numerous health benefits, including improved mobility, reduced joint pain, and significant reductions in markers like triglycerides, A1C, and fasting glucose levels. These health improvements, alongside the consistent support from her husband, affirm the effectiveness of intermittent fasting. Judy also speaks candidly about overcoming challenges, such as weight fluctuations after trips and the need to find her fasting "mojo" again with Gin's 28-day fast start program.For those starting intermittent fasting, Judy advises patience and emphasizes that it is a lifestyle change rather than a diet. She notes the importance of setting behavioral goals rather than focusing solely on the scale. Recognizing and avoiding foods that may hinder progress, like sugary or heavily processed items, and celebrating non-scale victories are key to long-term success. Judy's story exemplifies the transformative power of intermittent fasting, demonstrating that it's never too late to start a journey toward better health.Get Gin's books at: https://www.ginstephens.com/get-the-books.html. Good news! The second edition of Delay, Don't Deny is now available in ebook, paperback, hardback, and audiobook. This is the book that you'll want to start with or share with others, as it is a simple introduction to IF. It's been updated to include the clean fast, an easier to understand and more thorough description of ADF and all of your ADF options, and an all new success stories section. When shopping, make sure to get the second edition, which has a 2024 publication date. The audiobook for the second edition is available now! Join Gin's community! Go to: ginstephens.com/communityDo you enjoy Intermittent Fasting Stories? You'll probably also like Gin's other podcast with cohost Sheri Bullock: Fast. Feast. Repeat. Intermittent Fasting for Life. Find it wherever you listen to podcasts. Share your intermittent fasting stories with Gin: gin@intermittentfastingstories.comVisit Gin's website at: ginstephens.com Check out Gin's Favorite Things at http://www.ginstephens.com/gins-favorite-things.htmlSubscribe to Gin's YouTube Channel! https://www.youtube.com/channel/UC_frGNiTEoJ88rZOwvuG2CASee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.